AU2018208670A1 - Deuterium-enriched aldehydes - Google Patents
Deuterium-enriched aldehydes Download PDFInfo
- Publication number
- AU2018208670A1 AU2018208670A1 AU2018208670A AU2018208670A AU2018208670A1 AU 2018208670 A1 AU2018208670 A1 AU 2018208670A1 AU 2018208670 A AU2018208670 A AU 2018208670A AU 2018208670 A AU2018208670 A AU 2018208670A AU 2018208670 A1 AU2018208670 A1 AU 2018208670A1
- Authority
- AU
- Australia
- Prior art keywords
- deuterium
- jul
- pct
- methyl
- aldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01D—HARVESTING; MOWING
- A01D91/00—Methods for harvesting agricultural products
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
- A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Fats And Perfumes (AREA)
- Catching Or Destruction (AREA)
Abstract
Abstract The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a deuterium-enriched aldehyde wherein there are at least 6 x 1 0 A 18 molecules of the aldehyde in the composition, and wherein the aldehyde deuterium isotope is present in the molecule, in an amount greater than 0.10 percent of the aldehydic hydrogen atoms present in the molecule.
Description
The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a deuterium-enriched aldehyde wherein there are at least 6 x 10Λ18 molecules of the aldehyde in the composition, and wherein the aldehyde deuterium isotope is present in the molecule, in an amount greater than 0.10 percent of the aldehydic hydrogen atoms present in the molecule.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
DEUTERIUM-ENRICHED ALDEHYDES
FIELD OF THE INVENTION [0001] The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation.
BACKGROUND OF THE INVENTION [0002] Aldehydes are organic compounds containing a H-C(O)- moiety. They are used extensively in industrial processes. Formaldehyde, for instance, is produced on a scale of about 6,000,000 tons/year. Aldehydes are mainly used in the production of resins, but they also find application as precursors to plasticizers and other compounds used in the manufacturing of polymers. On a smaller scale, some aldehydes are used as ingredients in perfumes, flavors and compositions that modulate the behavior of insects, e.g., pheromone containing compositions. [0003] Aldehydes have a tendency to react with atmospheric oxygen to form carboxylic acids (H-C(O)- oxidizes to HO2C-) in a process known as auto-oxidation or autoxidation. The acids produced by autoxidation can lower the quality and usefulness of aldehyde-containing compositions.
[0004] Despite all of the research and development that has been directed to preservation of aldehydes, there is still a need in the art for improved aldehyde-containing compositions and related methods.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
SUMMARY OFTHE INVENTION [0005] In an aspect, the present invention provides a novel deuterium-enriched aldehyde of structure 1:
[0006] In another aspect, the present invention provides a novel method of making a deuteriumenriched aldehyde of structure 1, [0007] In another aspect, the present invention provides a novel composition, comprising: a deuterium-enriched aldehyde of structure 1, [0008] In another aspect, the present invention provides a novel composition, comprising: a deuterium-enriched aldehyde of structure 1 and an organic solvent.
[0009] In another aspect, the present invention provides a novel composition for modulating the behavior of insects, comprising: a deuterium-enriched aldehyde of structure 1 and an optional additional component suitable for the composition.
[0010] In another aspect, the present invention provides a novel method of manufacturing a resin or polymer using a deuterium-enriched aldehyde of structure 1.
[0011] These and other aspects, which will become apparent during the following detailed description, have been achieved by the inventors’ discovery that deuterium can slow the autoxidation of aldehydes.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
BRIEF DESCRIPTION OF THE FIGURES [0012] FIG. 1 shows a graph comparing the amount of air oxidation of benzaldehyde to benzoic acid where the hydrogen atom on the carbonyl group (i.e., H-C(O)Ph) is enriched in its deuterium isotope (/,e., >95% deuterium, “benzaldehyde-D”) and where it is not enriched (i.e., naturally occurring isotopic abundance, “benzaldehyde-H).
[0013] FIG. 2 shows a graph comparing the amount of air oxidation ofhexanal to hexanoic acid where the hydrogen atom of the carbonyl group (i.e., H-C(O)CSH| i) is enriched in its deuterium isotope (i.e., >95% deuterium, “hexanal-D”) and where it is not enriched (i.e., naturally occurring isotopic abundance, “hexanal-H”).
DETAILED DESCRIPTION OF THE INVENTION [0014] Definitions [0015] All examples provided herein are not intended to be limiting, [0016] “Alkyl” refers to an alkane chemical moiety. The alkanes may be linear, branched, or cyclic. Lower alkyl groups are those that include 1-6 carbon atoms. Higher alkyl groups are those that include 7-20 carbon atoms. Cyclic alkyl or cycloalkyl groups include 3-8 carbon atoms. Examples of such moieties include: CH3, CH2CH3, CH2CH2CH3, CH(CH3)2,
CH2CH2CH2CH3, CH(CH3)CH2CH3l CH2CH(CH3)2, C(CH3)3, CH2CH2CH2CH2CH3,
CH(CH3)CH2CH2CH3, CH?CH(CH3)CH2CH3, CH2CH2CH(CH3)2, ch2ch2ch2ch2ch2ch3, cyclopropyl, cyclobutyl, and cyclopentyl.
[0017] “Substituted alkyl” refers to an alkyl group where one or more of the hydrogen atoms have been replaced with another chemical group. Examples of such other chemical groups include: halo, OH, OR4 (where R4 is a lower alkyl group), CF3, OCF3, NH2, NHIG (where R4 is
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 a lower alkyl group), NR4R5 (where R4 and R are independently lower alkyl groups), CO JI.
CO2R6 (where IT, is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a tower alkyl group), C(O)NR2Rs (where R7 and Rs are independently lower alkyl groups), CN, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
[0018] “Halo” refers to Cl, F, Br, or I.
[0019] “Alkenyl” refers to a moiety containing only carbon and hydrogen that includes at least one double bond. The alkenes may be linear, branched, or cyclic. Lower alkenyl groups are those that include 2-6 carbon atoms. Higher alkenyl groups are those that include 7-20 carbon atoms. Cyclic alkenyl or cycloalkenyl groups include 5-8 carbon atoms. Examples of such moieties include: CH=CH2; CH=CHCH3; C1FCI1=CH; CH=CHCH2CH3; CH2CH=CHCH3;
CH2CH2CH=CH2; CH=CHCH2CH2CH3; CH=CHCH(CH3)2; CH2CH=CHCH2CH3;
CH2CH2CH=CHCH3;CH2CH2CH2CH=CH2;CH=CHCH2CH2CH2CH3;CH=CHCH2CH(CH3)2;
cyclopentenyl, and cyclohexenyl, [0020] “Substituted alkenyl” refers to an alkenyl group where one or more of the hydrogen atoms have been replaced with another chemical group. Examples of such other chemical groups include: CO2H, CO2R6 (where Rf, is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR2Rs (where R7 and Rs are independently lower alkyl groups),
CN, alkyl, substituted alkyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl. Where the replaced hydrogen atom is not on the carbon of the double bond, examples of such other chemical groups further include: halo, OH. OCH3, CF3, OCF3,
NH2, NHR4 (where R4 is a lower alkyl group), and NR4R5 (where R4 and R5 are independently lower alkyl groups).
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0021] “Alkynyl” refers to refers to a moiety containing only carbon and hydrogen that includes a triple bond. The alkynes may be linear or branched. Lower alkynyl groups are those that include 2-6 carbon atoms. Higher alkynyl groups are those that include 7-20 carbon atoms.
Examples of such moieties include: C=CH; C CCI E; CUTCIk CCCIECTE; CI EC CCI b:
(ΊΤ(ΊI-(’ (ΊIu C=CCH2CH2CH3; (ΊEC CCIECIE; CH2CH2C=CCH3; CH2CH2CH2C=CH;
C CCH E'I EC! ECH,: CH2C=CCH2CH2CH3; CH2CH2C=CCH2CH3; ClTCITCIECCCIE;
CH2CH2CH2CH2C=CH; and, C=CCH2CH(CH3)2.
[0022] “Substituted alkynyl” refers to an alkynyl group where one or more of the hydrogen atoms have been replaced with another chemical group. Examples of such other chemical groups include: CO2H, CCTRf, {where IT, is a lower alkyl group), C(O)NH2, C(O)NHRy {where Ry is a lower alkyl group), C(O)NR7R8 (where R7 and IT are independently lower alkyl groups), CN, alkyl, substituted alkyl, alkenyl, substituted alkenyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl. Where the replaced hydrogen atom is not on the carbon of the triple bond,
Examples of such other chemical groups further include: halo, OH, OCH3, CF3, OCF3, NH2, NHR4 (where R4 is a lower alkyl group), NR4R5 (where R4 and R5 are independently lower alkyl groups), [0023] “Heteroalkyl” refers to an alkyl group where at least one of the carbon atoms has been replaced with a heteroatom. Examples of heteroatoms include oxygen (“Ό”), nitrogen (“N”) and sulfur (“S”). The heteroalkanes may be linear, branched, or cyclic. Lower heteroalkyl groups are those that include 1 -6 carbons and heteroatoms. Higher heteroalkyl groups are those that include 7-20 carbons and heteroatoms. Examples of heteroalkyl groups include: CH2OCH3; CH2CH2OCH3; CH2N(R9)CH3 (where R9 is a lower alkyl group); CH2CH2N(R9)CH3 (where R9
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 is a lower alkyl group); CI kSCIk; ClkCI LSdC; tetrahydrofuran, tetrahydropyran, and moipholine, [0024] “Substituted heteroalkyl” refers to a heteroalkyl group where one or more of the hydrogen atoms has been replaced with another chemical group. The hydrogen atom that is replaced is typically not on a carbon atom directly attached to the heteroatom. Examples of such other chemical groups include: halo, OH, OCH3, CF3, OCF3, NH2, NHR4 (where R4 is a lower alkyl group), NR4R5 (where R4 and R? are independently lower alkyl groups), CO2H, CO2R0 (where R<, is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR7RS (where R7 and Rs are independently lower alkyl groups), CN, alkyl, aryl, and heteroaryl, [0025] “Aryl” refers to an aromatic group containing only carbon and hydrogen (e.g., (<11-. and
CioHe).
[0026] “Substituted aryl” refers to an aryl group where at least one of the hydrogen atoms has been replaced with another chemical group. Examples of such other chemical groups include:
halo, OH, OCH3, CF3, OCF3, NH2, NHR4 (where R4 is a lower alkyl group), NR4R, (where R4 and R5 are independently lower alkyl groups), CO2H, CO2Rft (where Re is a lower alkyl group),
C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR7Rjj (where R7 and Rs are independently lower alkyl groups), CN, alkyl, aryl, and heteroaryl.
[0027] “Heteroaryl” refers to an aromatic group where at least one of the carbon atoms has been replaced by a heteroatom. Examples of such heteroatoms include oxygen (“O”), nitrogen (“N”) and sulfur (“S”). Examples of heteroaryl groups include: C4H2O; C4H3N; C4H2S; and, C5H4N. [0028] “Substituted heteroaryl” refers to a heteroaryl group where at least one of the hydrogen atoms has been replaced with another chemical group. Examples of such other chemical groups
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 include: halo, OH, OCHi, CF3, OCF3, NH2, NHR4 (where R4 is a lower alkyl group), NR4R5 (where R4 and Rs are independently lower alkyl groups), CO2H, CO2Re (where Rf, is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R is a lower alkyl group), C(O)NR2Rg (where R7 and Rs are independently lower alkyl groups), CN, aryl, and heteroaryl.
[0029] Aspects [0030] In an aspect, the present invention is directed to a deuterium-enriched aldehyde of structure 1:
wherein, Rx is hydrogen, wherein the deuterium isotope is in an amount greater than 0.10 percent of the Rx hydrogen atoms. In certain cases, the deuterium isotope comprises greater than 1% of the Rx hydrogen atoms, or greater than 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%,
90%, or 95% percent of the Rx hydrogen atoms, R[, R2 and R3 are independently selected from hydrogen (where the hydrogen is un-enriched (i.e., naturally occurring) or is enriched in its deuterium isotope, e.g., more than 1%, 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95%), alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heteroalkyl, substituted heteroalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
Alternatively, the CR1R2R3 moiety forms a group selected from: an aryl, substituted aryl, heteroaryl, and substituted heteroaryl. Alternatively, the CR[R2 moiety forms a group selected from: an alkenyl and substituted alkenyl. Alternatively, the CR|R2R2 moiety forms a group a
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 group selected from: an alkynyl and substituted alkynyl. Optionally, the aldehyde is substituted with C(O)Ry, wherein Ry is hydrogen, wherein the deuterium isotope is optionally present in an amount greater than 0.10% of the Ry hydrogen atoms, provided that Rx is optionally H when the deuterium isotope is present in an amount greater than 0,10% of the Ry hydrogen atoms. In certain cases, the deuterium isotope comprises greater than 1% of the Ry hydrogen atoms, or greater than 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% percent of the Ry hydrogen atoms.
[0031] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde of structure 1:
wherein, there are at least 6 x 1018 molecules of the aldehyde, of structure 1. Compositions of the invention will typically comprise at least 6 x 1019 molecules, and may, for example, comprise at least 6 x 10 molecules, 6 x 10 molecules, 6 x 10“ molecules, or 6 x 10 molecules. Rx is hydrogen, wherein the deuterium isotope is in an amount greater than 0,10 percent of the Rx hydrogen atoms. In certain cases, the deuterium isotope comprises greater than 1% of the Rx hydrogen atoms, or greater than 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or
95% percent of the Rx hydrogen atoms. R,. R> and R; are independently selected from hydrogen (where the hydrogen is un-enriched (i.e., naturally occurring) or is enriched in its deuterium isotope, e.g., more than 1%, 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
95%), alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heteroalkyl, substituted heteroalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
Alternatively, the CR1R2R3 moiety forms a group selected from: an aryl, substituted aryl, heteroaryl, and substituted heteroaryl. Alternatively, the CR1R2 moiety forms a group selected from: an alkenyl and substituted alkenyl. Alternatively, the CR1R2R3 moiety forms a group a group selected from: an alkynyl and substituted alkynyl. Optionally, the aldehyde is substituted with C(O)Ry, wherein Ry is hydrogen, wherein the deuterium isotope is optionally present in an amount greater than 0.10% of the Ry hydrogen atoms, provided that Rx is optionally H when the deuterium isotope is present in an amount greater than 0.10% of the Ry hydrogen atoms. In certain cases, the deuterium isotope comprises greater than 1% of the Ry hydrogen atoms, or greater than 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% percent of the Ry hydrogen atoms.
[0032] In another aspect, reference to compositions comprising the “aldehyde of structure I”, means compositions comprising at least 0,1 mole of an aldehyde of structure 1, Compositions of the invention may, for example, comprise at least 0.2, 0.5, 1, 2, 3, 4, 5, 10, or 20 moles of an aldehyde of stricture 1.
[0033] In another aspect, reference to compositions comprising the “aldehyde of structure 1”, means compositions comprising at least I gram of an aldehyde of structure I, Compositions of the invention may, for example, comprise at least 5, 10, 20, 30, 40, 50, 100, 500, or 1,000 grams of an aldehyde of structure 1.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0034] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde of structure 1:
wherein:
there are at least 6 x 1018 molecules of the aldehyde;
Rx is hydrogen, wherein the deuterium isotope is present in an amount greater than 0.10% of the
Rx hydrogen atoms;
Ri, R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heteroalkyl, substituted heteroalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl;
alternatively, the CR|R3R3 moiety forms a group selected from: an aryl, substituted aryl, heteroaryl, and substituted heteroaryl;
alternatively, the CR[R3 moiety forms a group a group selected from: an alkenyl and substituted alkenyl;
alternatively, the CR1R2R3 moiety forms a group a group selected from: an alkynyl and substituted alkynyl; and, optionally, the aldehyde is substituted with C(O)Ry, wherein Ry is hydrogen, wherein the deuterium isotope is optionally present in an amount greater than 0.10% of the Ry
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 hydrogen atoms, provided that Rx is optionally H when the deuterium isotope is present in an amount greater than 0,10% of the Ry hydrogen atoms.
[0035] The following are examples of aldehydes according to the present invention:
1. A deuterium-enriched aldehyde of structure 1, where R| and R? are hydrogen, and Ri is a lower alkyl.
2. A deuterium-enriched aldehyde of structure 1, where Rj and R? are hydrogen, and R3 is a higher alkyl.
3. A deuterium-enriched aldehyde of structure 1, where R] and R? are hydrogen, and R3 is a substituted alkyl, where the substituted alkyl is a lower alkyl, and where the one or more other chemical groups are selected from: halo, OH, OR4 (where R4 is a lower alkyl group), CF3, OCF3, NH?, NHR4 (where R4 is a lower alkyl group), \R|R.
(where R4 and R5 are independently lower alkyl groups), CO3H, COiRf, (where Rfl is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR7Rs (where R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
4. A deuterium-enriched aldehyde of structure 1, where Rj and R? are hydrogen, and R3 is a substituted alkyl, where the substituted alkyl is a higher alkyl, and where the one or more other chemical groups are selected from: halo, OH, OR4 (where R4 is a lower alkyl group), CF3, OCF3, NH2, NHR4 (where R4 is a lower alkyl group), NR4R5 (where R4 and R5 are independently lower alkyl groups), CO?H, CO2R0 (where Rf, is a lower alkyl group), C(O)NH2, C(O)NHRy (where R7 is a lower alkyl group), C(O)NR7R« (where R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
II
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
5. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a tower alkenyl.
6. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a higher alkenyl,
7. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a substituted alkenyl, where the substituted alkenyl is a lower alkenyl, and where the one or more other chemical groups are selected from: CO2H, CO2Re (where Re is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR7Rs (where R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
8. A deuterium-enriched aldehyde of structure 1, where Rj and R2 are hydrogen, and R3 is a substituted alkenyl, where the substituted alkenyl is a higher alkenyl, and where the one or more other chemical groups are selected from: CO2H, CO2Re (where Ri. is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR7R8 (where R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl,
9. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a tower alkynyl,
10. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a higher alkynyl.
11. A deuterium-enriched aldehyde of structure 1, where R] and R2 are hydrogen, and R3 is a substituted alkynyl, where the substituted alkynyl is a lower alkynyl, and where the chemical groups are selected from: CO2H, CO2Re (where Re is a lower alkyl
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 group), C(O)NH2, C(O)NHR7 (where R? is a lower alkyl group), C(O)NRyRii (where R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
12. A deuterium-enriched aldehyde of structure 1, where R| and R? are hydrogen, and Ri is a substituted alkynyl, where the substituted alkynyl is a higher alkynyl, and where the chemical groups are selected from: COiH. COiRe, (where Rf, is a lower alkyl group), C(O)NH2, C(O)NHR7 (where R7 is a lower alkyl group), C(O)NR2Rii (where
R7 and Rs are independently lower alkyl groups), CN, aryl, substituted aryl, heteroaryl, and substituted heteroaryl.
13. A deuterium-enriched aldehyde of structure 1, where R) and R2 are hydrogen, and R2 is a lower heteroalkyl.
14. A deuterium-enriched aldehyde of structure 1, where Rj and R2 are hydrogen, and Ri is a higher heteroalkyl.
15. A deuterium-enriched aldehyde of structure 1, where Rj and R2 are hydrogen, and Ri is a substituted heteroalkyl, where the substituted heteroalkyl is a lower heteroalkyl.
16. A deuterium-enriched aldehyde of structure 1, where Rj and R2 are hydrogen, and R2 is a substituted heteroalkyl, where the substituted heteroalkyl is a higher heteroalkyl.
17. A deuterium-enriched aldehyde of structure 1, where Ri and R2 are hydrogen, and R2 is aryl.
18. A deuterium-enriched aldehyde of structure 1, where R| and R? are hydrogen, and R2 is substituted aryl.
19. A deuterium-enriched aldehyde of structure 1, where Rj and R2 are hydrogen, and R3 is heteroaryl.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
20. A deuterium-enriched aldehyde of structure 1, where CRJARi is aryl.
21. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 is substituted aryl,
22. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 is heteroaryl.
23. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 is substituted heteroaryl.
24. A deuterium-enriched aldehyde of structure 1, where CR1R2 is alkenyl and R3 is hydrogen.
25. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 is substituted alkenyl and R3 is hydrogen.
26. A deuterium-enriched aldehyde of structure 1, where CR1R2 is alkenyl and R3 is alkyl.
27. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 is substituted alkenyl and R3 is alkyl.
28. A deuterium-enriched aldehyde of structure 1, where R] is alkyl substituted with
C(O)Ry.
29. A deuterium-enriched aldehyde of structure 1, where Rj is alkyl substituted with
C(O)Ry and R2 and R3 are hydrogens.
30. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 aryl substituted with C(O)Ry.
31. A deuterium-enriched aldehyde of structure 1, where CR1R2R3 substituted aryl substituted with C{O)Ry.
[0036] Additional deuterium-enriched aldehydes of the present invention include those numbered 2-64 shown below.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
Rv
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
(grandlure IV, E-(3,3-dimethyl)-cyclohexylideneacetaldehyde)
(grandlure III, Z-(3,3-dinietliyl)-cyclohexylideneacetaIdehyde)
Rx (Zll-16:Ald)
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
R* (Z9-16:Ald)
Rx (Z9-14:Ald)
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
Rx
Rx
(Zll-14:Ald)
Rx (Ell-14:Ald)
Rs
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
0
(18:Ald)
Rx (E2-9:Ald)
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
O
(vanillin)
O-
(14Me-Z8-16:Ald, Z-trogodermal)
Rv
O:
\=/ (R,Z-trogodermal)
ΛΎ7
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
(R,E-trogodermal)
Rx
,RX
O:
(StZ-trogodermal)
(4,8-Me2-10:Ald, tribolure)
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
(4R,SR-Me2-10:Ald, R,R-tribolure) (λ \
R.
(4Ri8S-Me2-10:Ald, R,S-tribolure)
(grand! u re, E/Z-(3,3-dimethyl)-cyelohexy!ideneacetaldehyde)
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
(Z7,Zll,E13-16:Ald)
Rx
(7-heptyloxybutanal).
[0037] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 2% of the hydrogen atoms present in RK.
[0038] Additional deuteri um-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 10% of the hydrogen atoms present in Rx.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0039] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 20% of the hydrogen atoms present in Rx.
[0040] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 30% of the hydrogen atoms present in Rx, [0041] Additional deuterium-enriched aldehydes ofthe present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 40% of the hydrogen atoms present in Rx, [0042] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 50% of the hydrogen atoms present in Rx, [0043] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 60% of the hydrogen atoms present in Rx, [0044] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 70% of the hydrogen atoms present in Rx, [0045] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 80% of the hydrogen atoms present in Rx.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0046] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 90% of the hydrogen atoms present in Rx.
[0047] Additional deuterium-enriched aldehydes of the present invention include aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 95% of the hydrogen atoms present in Rx, [0048] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64, [0049] Reference to “compositions comprising compounds 2-64” means compositions comprising at least 6 x 1018 molecules of at least one of aldehydes 2-64, typically at least 6 x 1019 molecules, and may, for example, comprise at least 6 x 10 molecules, 6 x 10 molecules, 6 x 10 molecules, or 6 x 1023 molecules. Rx is hydrogen, wherein the deuterium isotope is in an amount greater than 0.10 percent of the Rx hydrogen atoms. In certain cases, the deuterium isotope comprises greater than 1 % of the hydrogen atoms, or even greater than 2%, 5%, 10%,
20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% of the hydrogen atoms.
[0050] In another aspect, reference to “compositions comprising compounds 2-64” means compositions comprising at least 0.1 mole of at least one of aldehydes 2-64. Compositions of the invention may, for example, comprise at least 0.2, 0.5, 1,2, 3, 4, 5, 10, to 20 moles of at least one of compounds 2-64.
[0051] In another aspect, reference to “compositions comprising compounds 2-64” means compositions comprising at least 1 gram of at least one of aldehydes 2-64. Compositions of the invention may, for example, comprise at least 5, 10, 20, 30, 40, 50, 100, 500, to 1,000 grams of at least one of compounds 2-64.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0052] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 2% of the hydrogen atoms present in Rx.
[0053] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 10% of the hydrogen atoms present in Rx.
[0054] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 20% of the hydrogen atoms present in Rx.
[0055] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in R, is in an amount greater than 30% of the hydrogen atoms present in Rx, [0056] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 40% of the hydrogen atoms present in Rx.
[0057] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 50% of the hydrogen atoms present in Rx.
[0058] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 60% of the hydrogen atoms present in Rx.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0059] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 70% of the hydrogen atoms present in Rx.
[0060] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 80% of the hydrogen atoms present in Rx.
[0061] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in Rx is in an amount greater than 90% of the hydrogen atoms present in Rx.
[0062] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 2-64 wherein the deuterium isotope in R, is in an amount greater than 95% of the hydrogen atoms present in Rx, [0063] Additional deuterium-enriched aldehydes of the present invention include aldehydes 65358 listed in the Table A below. For each aldehyde listed in the table, the original aldehyde hydrogen (C(O)-H) has been replaced by Rx (C(O)-RX). For example, fomnaldehyde-Rx {CHORx) is HC(O)-RX.
Table A
Ex, | Name | Formula |
65. | Form aldeh yde-Rx | CHO-RX |
66. | 2-Meth yl-2-pro penal- R x | C4H5O-Rx |
67. | 2-Methylpropanal-Rx | C4H7O-Rx |
68. | 2-Propenal“Rx | C4H3O-Rx |
69. | 2-Butenal-Rx | C4H5O-Rx |
70. | 2-Methyl-2-b utenal-Rx | c5h7o-rx |
71. | 2-Methylenebutanal-Rx | c5h7o-rx |
72. | 3-Methyl-2-butenal-Rx | c5h7o-rx |
73. | 3-Methyl-3-butenal-Rx | c5h7o-rx |
74. | 3-Meth ylbutanal-Rx | CH>O-RX |
75. | (E)-2-Pentenal-Rx | c5h7o-rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
76. | 2-Methylenepentanal-Rx | C6H9O-Rx |
77. | 2-Pentenal-Rx | CsHyORx |
78. | 3-Methyl-1 -(vinyloxy)-butane-Rx | CvHnO-Rx |
79. | 4- Methyl pentanal - Rx | CftHuO-Rx |
80. | Furan-2-carbaldehyde-Rx | C^HiO^-Rx |
81. | (E)-2-Hexenal-Rx | C6H9O-Rx |
82. | (E)-4-oxo-2-Hexenal-Rx | C6H7O2-Rx |
83. | (E,E)-2,4-Dimethyl-2,4-hexadienal-Rx | C8H|,O-Rx |
84. | (E,E)-2,4-Hexadienal-Rx | C6H7O-Rx |
85. | (Z)-2-Hexenal-Rx | C6H9O-Rx |
86. | (Z) -3-Hexenal -Rx | CeH9O-Rx |
87. | (Z)-4-oxo-2-Hexenal-Rx | C6H7O2-Rx |
88. | !-Hexenal-Rx | C6H9O-Rx |
89. | 2,3-Dihydroxybenzaldehyde-Rx | C7H<;Oi-Rx |
90. | 2-Hexenal-Rx | C6H9O-Rx |
91. | 3-((E)-2-Hexenoxy)-hexanal-Rx | C12H2,O2-Rx |
92. | 3,5-Dimethylhexanal-Rx | C8H15O-Rx |
93. | 3-EthoxyhexanaERx | C8H,5O2’Rx |
94. | 3-Hydroxybenzaldehyde-Rx | C7H,O2-Rx |
95. | 3-HydiOxyhexanal-Rx | Ο,ΗπΟΛ |
96. | 4-Hydroxy-3,5-dimethoxybenzaldehyde-RK | c9h9o4-rx |
97. | 4-Hydroxybenzaldehyde-Rx | CvHA-Rx |
98. | 5-Methylhexanal-Rx | C7HnO-Rx |
99. | Hexanal-Rx | CfcHi ,O-RX |
100. | (1R,2S,5S)-Iridodial-Rx | CioHi502-Rx |
101. | (]R,5S)-6,6-Dimethylbicyclo[3.1 ,l]hept-2-ene-2-carbaldehyde-Rx | C,oH130-Rx |
102. | (!S,2R.3S)-2-( I-Formyl vmy1)-5-methylcyclopentanecarbaldehydeRx | C,0HbO2-Rx |
103. | (3S,8R)-2-Methyl-5-(1 -formylethyl)-1 -cyclopentene-1carbaldebyde-Rx | CioFIbOi-Rx |
104. | (3S,8S)-2-Methyl-5-( 1 -formylethyl)-1 -cyclopentene-1 carbaldehyde-Rx | C10H13O2-Rx |
105. | (5S,8S)-2-Methyl-5-(l-formylethyl)-1-cyclopentene-1carbaldehyde-Rx | C|oH]302-Rx |
106. | (E)-2-(2-Hydroxyethyl)-6-methyl-2,5-heptadienal-Rx | C10H15O2-Rx |
107. | (E)-2-(2-HydiOxyethylidene)-6-methyl-5-heptenal-Rx | C|oH1502-Rx |
108. | (E)-2-Heptenal-Rx | C7H| ,O-Rx |
109. | (E) -2- Isopropyl-5 - meth y 1 -2-hexen al -Rx | CjoH|70-Rx |
110. | (E,Z)-2,4-Heptadienal-Rx | C7H9O-Rx |
111. | (R)-2-((l R,2R,3S)-3-Methyl-2-vinylcyclopentyl)-propanal-Rx | CuH19O2-Rx |
112. | (R)-2-((lS,2S,3S)-3-Methyl-2-vinylcyclopentyl)-propanal-Rx | ChH19O2-Rx |
113. | (R)-2,6-Dimethyl-5-heptenal-Rx | C9H|5O-Rx |
114. | (R)-7-Hydroxy-6,7-dihydro-5H-pyrrolizidine-l-carboxaldehyde-Rx | C8H«NO2-Rx |
115. | (S)-4-(Prop-1 -en-2-yl)-cyclohex-1 -enecarbaldehyde-Rx | c10hbo-rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
116. | (S)-7 -Hydroxy-6,7-dihydro-5 H-pyrrolizidine-l-carbo xaldehyde-Rx | C8H8NO2-Rx |
117. | (Z)-2-Isopropyl-5-methyl-2-hexenal-Rx | c10h17o-rx |
118. | !-Fomiyl-6,7-dihydiO-5H-pyiTolizine-Rx | C8H8NO-Rx |
119. | l-Formyl-7-hydiOxy-6,7-dihydro-5H-pyiTolizine-Rx | CJbAOAA |
120. | 2-(3-Methylcyclopentyl)-propanal-Rx | C9H|3O-Rx |
121. | 2,6-Di meth yl-5-heptenal-Rx | C9H15O-Rx |
122. | 2-Acetyl-5-methylcyclopentanecarbaldehyde-Rx | C9H13O2-Rx |
123. | 2-Methoxybenzaldehyde-Rx | C8H7O2-Rx |
124. | 2-Methyl-l-cyclopentenecarboxaldehyde-Rx | C7H9O-Rx |
125. | 3,3-Dimethyl-5-oxo-7-oxabicyclo[4.1.0]heptane-l-carbaldehyde-Rx | C9H| [O3-Rx |
126. | 3-Hydroxybenzene-l,2-dicarbaldehyde-Rx | CsH5O3-Rs |
127. | 3-Methylbenzaldehyde-Rx | c8h7o-rx |
128. | 4-(Heptyloxy)-butanal-Rx | C]|H2]O2-Rx |
129. | 4-Methoxybenzaidehyde-Rx | c8h7o2-rx |
130. | 6,7-Dihydro-5 H-pyrrolizine-l-carboxaldehyde-Rx | c8h8no-rx |
131. | 6.7-Dihydro-7-oxo-5 H-pyrrolizine-l-carbaldehyde-Rx | c8h6no2-rx |
132. | 6-Methylheptanal-Rx | c8h15orx |
133. | 7-Hydroxy-6,7-dihydiO-5H-pyiTolizin-1 -carboxaldehyde-Rx | C8H8NO2-Rx |
134. | Benzaldehyde-Rx | C7H5O-Rx |
135. | Cyc lohex anedial-Rx | C8HuO2-Rx |
136. | Heptanal-Rx | C7H13O-Rx |
137. | Plagiodial-Rx | C,oHn02-R, |
138. | (lR,2S)-cis-2-Isopropenyl- l-methylcyclobutaneethanal-Rx | CioH150-Rx |
139. | (1R,2S,5R,8R)-Iridodial-Rx | C,0Hj5O2-Rx |
140. | (4S )-(3-Oxo prop-1 -en-2-yl)-cyclohex- l-enecarbaldehyde-Rx | CioHj |O2-RX |
141. | (E)-2-(3,3-Dimethylcyclohexylidene)-acetaldehyde-Rx | C,0H,5O-Rx |
142. | (E)-2-(4-Methyl-3-pentenyl)-butenedial-Rx | C,0H,3O2-Rx |
143. | (E)-2-(4-Methyl-3-pentenylidene)-butanedial-Rx | CioHj302-Rx |
144. | (E)-2,7-Octadienal-Rx | C8H| [O-Rx |
145. | (E)-2-Methyl-5-(3-furyl)-2-pentenal-Rx | CioH]]02-Rx |
146. | (E)-2-Octenal-Rx | C8H13O-Rx |
147. | (E)-3,7-Dimethyl-2,6-octadienal-Rx | CioH150-Rx |
148. | (E)-3,7-Dimethyl-2,6-octadienal-Rx | C,oH,50-Rx |
149. | (E)-4-oxo-2-Octenal-Rx | C8H,|O2-Rx |
150. | (E)-7-Methyl-2-octen al -R x | C9H15O-Rx |
151. | (E,E)-2,4-Octadienal-Rx | C8H„O-Rx |
152. | (E,E)-2,6-Dimethyl-8-hydroxy-2,6-octadienal-Rx | CioHi502-Rx |
153. | (E,E)-2,6-Octadienal-Rx | C8H,|O-Rx |
154. | (E,E)-2,6-Octadienedial-Rx | C8H9O2-Rx |
155. | (E,Z)-2,4-Octadienal-Rx | C8HhO-Rx |
156. | (E,Z)-2,6-Octadienal-Rx | C8H„O-Rx |
157. | (Z)-2-(3,3-Dimethylcyclohexylidene)-acetaldehyde-Rx | CJ0H15O-Rx |
158. | (Z)-3,7 - Dimethyl-2,6 -octadien al -Rx | C10Hi5O-Rx |
159. | (Z,E)-3,7-Dimethyl-2,6-octadienal-Rx | CioHlsO-Rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
160. | 1-Octenal-Rx | C8Hi3O-Rx |
161. | 2-(1-Form ylvinyl)-5-methylcyclopentanecarbaldehyde-Rx | C10HI3O2-Rx |
162. | 2,6,6-Trimethyl-1 -cyclohexene-1 -carbaldehyde~Rx | CioHisO-Rx |
163. | 2-Ethyloctanal-Rx | CioH|90-Rx |
164. | 2-Hydroxy-6-methylbenzaldehyde-Rx | C8H7O2-Rx |
165. | 2-Metbyl benzaldehyde-Rx | C8H7O-Rx |
166. | 2-Octenal-Rx | c8h13orx |
167. | 2-Phenyl propenal-Rx | C9H7O-Rx |
168. | 3,7 - Dimethyl-6 -octen al - Rx | C,0H,7O-Rx |
169. | 3-Ethoxy-4-hydroxybenzaldehyde-Rx | C9H9O3-Rx |
170. | 3-Ethyl benzaldehyde-Rx | C9H9O-Rx |
171. | 3-Isopropyl-6-methyl benzaldehyde-Rx | C„H,3O-Rx |
172. | 3-Octenal-Rx | CaHoO-Rx |
173. | 3-oxo-4-Isopropyl idene-1 -cyclohexene-1 -carboxyaldehyde-Rx | CjoHnOj-Rx |
174. | 4-Hydroxy-2-methyl benzaldehyde-Rx | C8H7O2-Rx |
175. | 4-Hydroxy-3-methoxybenzaldehyde-Rx | C8H7O3-Rx |
176. | 4-Isopropenyl-1 -cyclohexene-1-carbaldehyde-Rx | c10h13o-rx |
177. | 4-Isopropenyl-3-oxo-1 -cyclohexene-1 -carboxyaldehyde-Rx | CjoHhOi-Rx |
178. | 4-oxo-Octenal-Rx | C8H| ,(ARX |
179. | 4S-4-Isopropenyl-3-oxo-l-cyclohexene-l-carboxyaldehyde-Rx | CioH]jO?-Rx |
180. | 6,6-Dimethylbicyclo[3.1.1 ]hept-2-ene-2-carbaldehyde-Rx | c10h13o-rx |
181. | 7-Methyloctanal-Rx | C9H|7O-RX |
182. | Anisomorphal-Rx | CI0H13O2-R2 |
183. | cis-2-Isopropenyl-l-methy!cyclobutaneethanal-Rx | CjoHjsO-Rx |
184. | Octanal-Rx | C8H[5O-Rx |
185. | Peruphasmal-Rx | CioH1302-Rx |
186. | (E)-4,8- Nonadienal- Rx | C9H,3O-Rx |
187. | (E)-8-Methyl-2-nonenal-Rx | CjoHj70-Rx |
188. | (E,E)-2,4-Nonadienal-Rx | C9Hl,O-Rx |
189. | (Ε,Ε,Ε) -2,4,6- Nonatrienal-Rx | C9Hi,O-Rx |
190. | (E,E,Z)-2,4,6-Nonatrienal-Rx | C9HuO-Rx |
191. | (E,Z)-2,6-Nonadiena]-Rx | C9H13O-Rx |
192. | (E,Z,Z)-2,4,6-N onatrienal-Rx | C9HuO-Rx |
193. | (Z)-3-Nonenal-Rx | C9Hl5O-Rx |
194. | (Z)-4,8-Nonadienal-Rx | c9h13o-rx |
195. | (Z)-4-Nonenal-Rx | C9H15O-Rx |
196. | (Z)-8-Methyl-2-nonenal-Rx | CioHnO-Rx |
197. | 2-Phenyl-2-butenal-Rx | CjoH90-Rx |
198. | 3-(4-Methoxyphenyl)-2-propenal-Rx | CjoH902-Rx |
199. | 3-Phenyl-2-propenal-Rx | C9H7O-Rx |
200. | 3-Phenyl propanal-Rx | C9H9O-Rx |
201. | 6-Ethyl benzaldehyde-Rx | C9H9O-Rx |
202. | 8-Meth ylnonanal-R x | CjoHj90-Rx |
203. | 9-Acetyloxynonanal-Rx | ChH]9O3-Rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
204. | Nonanal-Rx | c9h,7o-rx |
205. | (E)-2,9-Decadienal-Rx | c10h15o-rx |
206. | (E)-2-Decenal-Rx | CioHnO-R, |
207. | {E)-4-oxo-2-Decenal-Rx | CioHJ502-Rx |
208. | (E)-8-Hydroxy-4,8-dimethyl-4,9-decadienal-Rx | C,2H19O2-Rx |
209. | (E)-9-Methyl-2-decenal-Rx | C]]H!9O-Rx |
210. | (E,E)-2,4-Decadienal-Rx | c10h15o-rx |
211. | (E,Z)-2,4-Decadienal-Rx | CioHisO-Rx |
212. | {Z)-4-Decenal-Rx | C,0H,7O-Rx |
213. | (Z)-5-Decenal-Rx | CjoHj70-Rx |
214. | (Z)-9-Methyl-2-decenal-Rx | C]jHii)O-Rx |
215. | 1-Decenal-Rx | C10H17O-Rx |
216. | 2-Decenal-Rx | Ci0H17O-Rx |
217. | 2-Ethyldecanal-Rx | Cj2H23O-Rx |
218. | Decanal-Rx | CioHi(jO-Rx |
219. | (5E)-2,6,10-Trimethyiundeca-5,9-dienal-Rx | C]4H23O-RX |
220. | (E)-2-Undecenal-Rx | C„H19O-Rx |
221. | (E)-6-Ethyl-2,10-dimethyl-5,9-undecadienal-Rx | c15h25o-rx |
222. | 10-Urtdecenal-Rx | C„H,9O-Rx |
223. | 2-Butyl-2-octenal-Rx | Ci2H2,O-Rx |
224. | 5-Methyl-2-phenyl-2-hexenal-Rx | c13h15o-rx |
225. | 8-Isopropyl-5-methyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-2carbaldehyde-Rx | C15HnO-Rx |
226. | syn-4,6-Dimethylundecanal-Rx | C]3H25O-Rx |
227. | Undecan al-Rx | CiiH2]O-Rx |
228. | (3R,5R,9R)-3,5,9-Trimethyldodecanal-Rx | C15H29O-Rx |
229. | (3S,6E)-7-Ethyl-3,11 -dimethyldodeca-6,10-dienal-Rx | C|6H27O-Rx |
230. | (9R)-3,5,9 -Trimeth y!dodecanal-Rx | Cj5H29O-Rx |
231. | (E)-10-Dodecenal-Rx | Ci2H2jO-Rx |
232. | (E)-2-Dodecenal-Rx | Cj2H2]O-Rx |
233. | (E)-3,7,l l-Trimethyl-6,10-dodecadienal-Rx | Ci5H25O-Rx |
234. | (E)-6-Dodecenal-Rx | C12H2iO-Rx |
235. | (E)-7-Dodecenal - Rx | C|2H2|O-Rx |
236. | (E)-8-Dodecenal-Rx | Ci2H2,O-Rx |
237. | (E)-9,11-Dodecadienal-Rx | Ci2Hi9O-Rx |
238. | {E)-9-Dodecenal-Rx | C12H21O-Rx |
239. | (E,E)-3,7,11 -Tri methyl-2,6,10-dodecatrienal-Rx | C|5H23O-Rx |
240. | (E,E)-7-Ethyl-3,11-dimethyl-2,6,10-dodecatrienal-Rx | Cji,H25O-Rx |
241. | (E,E)-8,10-Dodecadienal-Rx | Ci2Hi9O-Rx |
242. | (E,E,E)-3,7-Dimethyl-8,1 l-dioxo-2,6,9-dodecatrienal-Rx | C14H17O3-Rx |
243. | (E.E.Zjrii^-Dinnethyl-S. 11 -dioxo-2,6,9-dodecatrienal-Rx | C,4H)7O3-Rx |
244. | (E,Z)-5,7-Dodecadienal-Rx | C]2H]9O-Rx |
245. | (E,Z)-7,9-Dodecadienal-Rx | Ci2Hjt)O-Rx |
246. | (E,Z)-8,10- Dodecadienal-Rx | C12H19O-RX |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
247. | (S,E)-3,7,ll-Trimethyl-6,10-dodecadienal-Rx | Ci5H25O-Rx |
248. | (Z)-2-Methyl-5-(( 1 R,5R,6S)-2,6-dimethylbicyc)o[3.1,1 ]hept-2-en6-yl)-pent-2-enal-Rx | C|5H21O-RX |
249. | (Z)-5 -Dodecenal - Rx | C|2H2)O-Rx |
250. | (Z)-7-Dodecenal-Rx | C|2H2)O-Rx |
251. | (Z)-9,11 -Dodecadienal-Rx | Ci2H]()O-Rx |
252. | (Z)-9-Dodecenal~Rx | Ci2H2,O-Rx |
253. | (Z,E)-3,7,1 i -Tri methyl-2,6,10-dodecatrienal-Rx | C,5H23O-Rx |
254. | (Z,E)-5,7-Dodecadienal-Rx | Cj2Hj9O-Rx |
255. | (Z,E)-7-Ethyl-3,11-dimethyl-2,6,10-dodecatrienal-Rx | Ci6H25O-Rx |
256. | (Z,E)-8,10-Dodecadienal-Rx | Ci2Hj9O-Rx |
257. | (Z,Z)-5,7-Dodecadienal-Rx | C12H19O-Rx |
258. | 2-Ethyldodecana]-Rx | CJ4H27O-Rx |
259. | 3,7,11 -Tri methy 1 - (E)-6,1O-dodecadienal -Rx | C15H25O-Rx |
260. | Dodecanal-Rx | Ci2H23O-Rx |
261. | syn-4,6-Dimethyldodecanal-Rx | C]4H27O-Rx |
262. | (3S,4R,6E, 10Z)-3,4,7,11 -Tetramethyl-6,1O-tridecadienal-Rx | C17H29O-Rx |
263. | (Z)-4-T ridecenal-Rx | CJ3H23O-Rx |
264. | 13-Acetyloxytridecanal-Rx | Ci5H27O2-Rx |
265. | Tridecan al-Rx | Ci3H23O-Rx |
266. | (E)-l 1,13-Tetradecadienal-Rx | CmH^O-R, |
267. | (E,E)-8,I0-Tetradecadienal-Rx | Ci4H2iO-Rx |
268. | (E,Z)-4,9-Tetradecadienal-Rx | C]4H24O-RX |
269. | (Z)-l l,13-Tetradecadienal-Rx | C!4H22O-Rx |
270. | (Z) -5-Tetradecenal-Rx | Ci4H23O-Rx |
271. | (Z)-7-Tetradecenal-Rx | C14H25O-Rx |
272. | {Z)-9,13-Tetradecadien-l 1 -ynal-Rx | C|4H19O-Rx |
273. | (Z,E)-9,12-Tetradecadienal-Rx | C,4H23O-Rx |
274. | (Z,Z)-8,10-Tetradecadienal-Rx | Ci4H2iO-Rx |
275. | (Z,Z)-9,11-Tetradecadienal-Rx | C14H23O-Rx |
276. | 10,12~Tetradecadienal-Rx | C|4H23O-Rx |
277. | 2-Ethyltetradecanal~Rx | C,6H3iO-Rx |
278. | 3-oxo-13-Tetradecenal-Rx | C,4H21O2-Rx |
279. | 3-oxo-Tetradecanal-Rx | C j4H23O2-Rx |
280. | 5,8-Tetradecadienal-Rx | Ci4H23O-Rx |
281. | 5-Tetradecenal-Rx | C14H25O-Rx |
282. | (E)-5,9-Dimethyl-2-(6-methylhept-5-en-2-yl)-deca-4,8-dienal-Rx | c20h„o-rx |
283. | (E,Z)-9,11-Pentadecadienal-Rx | C)5H25O-Rx |
284. | (Z)-1O-Pentadecenal-Rx | Ci5H27O-Rx |
285. | (Z)-6,14-Pentadecadienal-Rx | Ci3H25O-Rx |
286. | (Z,Z)-9,11-Pentadecadienal-Rx | CisH^O-Rx |
287. | 2-Hexyl-2-decenal-Rx | C]6H29O-Rx |
288. | Pentadecanal-Rx | Ci5H29O-Rx |
289. | (1R)-Pimaral-Rx | C2qH29O-Rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
290. | (E)-10- Hexadecenal-Rx | CisHjtjO-Rx |
291. | (E)-l 1-Hexadecenal-Rx | C16H2,jO-Rx |
292. | (E,E)-10,14-Hexadecadienal-Rx | C|6H37O-RX |
293. | (E,E)-1 l,13-Hexadecadienal-Rx | C16H27ORx |
294. | (E,E)-9,11-Hexadecadienal-Rx | CifiH^vO-Rx |
295. | (Ε,Ε,Ε)-ΙΟ. J 2,14-Hexadecatrienal-Rx | C]r,H23O-Rx |
296. | (E,E,E)-3,7,11,15-tetiamethyl-2,6,10,14-hexadecatetraenal-Rx | C20H31O-Rx |
297. | (Ε,Ε,Ζ)-10, J 2 J 4-Hexadecatrienal-Rx | Ci;>ll?,ORx |
298. | (E,E,Z)-4,6,11 -Hexadecatrienal-Rx | c,6h25o-rx |
299. | (E,E,Z,Z)-4,6,11,13-Hexadecatetraenal-Rx | Ci6H33O-Rx |
300. | (E,Z)-10,12-Hexadecadienal-Rx | Ci6H27O-Rx |
301. | (E,Z)-J l,13-Hexadecadienal-Rx | C16H27O-Rx |
302. | {E,Z)-4,6-Hexadecadienal-Rx | C|6H27O-Rx |
303. | (E,Z)-6,11-Hexadecadienal-Rx | C,6H27O-Rx |
304. | (E,Z)-8,11-Hexadecadienal-Rx | Ci6H27O-Rx |
305. | (E,Z)-9,11-Hexadecadienal-Rx | Ck,H27O-Rx |
306. | (Z)-10-Hexadecenal-Rx | Ck,H29O-Rx |
307. | (Z)-12-HexadecenaERx | C,6H29O-Rx |
308. | (Z)-13-Hexadecen-ll-ynal-Rx | C!6H25O-Rx |
309. | (Z)-3-oxo-9-Hexadecenal-Rx | Ci6H27O2-Rx |
310. | (Z,E)-10,12-Hexadecadienal-Rx | C16H27O-Rx |
311. | (Z,E)-1 l,13-Hexadecadienal-Rx | c16h27o-rx |
312. | (Z,E)-7,11-Hexadecadienal-Rx | C|6H27O-Rx |
313. | (Z,E)-9,11-Hexadecadienal-Rx | Cjf,H27O-Rx |
314. | (Z,Z)-10,12-Hexadecadienal-Rx | Ck,H27O-Rx |
315. | (Z,Z)-1 l,13-Hexadecadienal-Rx | c16h27o-rx |
316. | (Z,Z)-9,11-Hexadecadienal-Rx | C|6H27O-Rx |
317. | 11-Hexadecynal-Rx | c]6h27o-rx |
318. | 2-Methylhexadecanal - Rx | Cj7H33O-Rx |
319. | 7-Hexadecenal-Rx | Ci6H29O-Rx |
320. | 9-HexadecenaLRx | c16h2(J0-rx |
321. | (Z)-9- Heptadecenal-Rx | C,7H3iO-Rx |
322. | 1 -Heptadecenal-Rx | c17h3,o-rx |
323. | 2-Heptadecenal-Rx | c17h31o-rx |
324. | Heptadecanal-Rx | C]7H33O-Rx |
325. | (E)-l l-Octadecenal-Rx | C18H33O-Rx |
326. | (E)-13-0ctadecenal-Rx | C)8H33O-Rx |
327. | (E)-14- Octadecenal-Rx | C,8H33O-Rx |
328. | (E)-2-0ctadecenal- Rx | C18H33O-Rx |
329. | {E,E)-1 l,14-0ctadecadienal-Rx | c18h31o-rx |
330. | (E,Z)-2,13-Octadecadienal-Rx | C|8H3)O-Rx |
331. | (E,Z)-3,13-0ctadecadienal-Rx | C|8H3jO-Rx |
332. | (Z)-l 1-Octadecenal-Rx | Cj8H33O-Rx |
333. | (Z)-13-0ctadecenal-Rx | Ci8H33O-Rx |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
334. | (Z)-9-Octadecenal-Rx | C18H33O-RX |
335. | (Z,Z)-1 l,13-Octadecadienal-Rx | Ci8H31O-Rx |
336. | (Ζ,Ζ)-13,15-Octadecadienal-Rx | CisHjjiO-Rx |
337. | (Z,Z)-3,13-Octadecadienal-Rx | C18H31O-RX |
338. | (Z,Z)-9,12-Octadecadienal-Rx | Ci8H3]O-Rx |
339. | (Z,Z,Z)-9,12,15-Octadecatrienal-Rx | Ci8H29O-Rx |
340. | ! -Octadecenal-Rx | Ci8H33O-Rx |
341. | 9-Octadecenal-Rx | C18H33O-Rx |
342. | Octadecanal-Rx | C,8H35O-Rx |
343. | (Z)-10-N onadecenal-Rx | C]9H35O-Rx |
344. | (Z)-9-Nonadecenal-Rx | C19H35O-Rx |
345. | (Z)l 1-Eicosenal-Rx | c20h37o-rx |
346. | !2-Deacetoxy-12-oxo-scalaiadial-Rx | C25H35O3-Rx |
347. | 1-Eicosenal-Rx | c20h37o-rx |
348. | Deacetylscalaradial-Rx | C2iH37O3-Rx |
349. | Eicosanal-Rx | C2oH390-Rx |
350. | Scalaradial-Rx | C27H39O4-Rx |
351. | Docosanal-Rx | C22H43O-Rx |
352. | Tetracosanal-Rx | C24H47O-Rx |
353. | Pentacosanal-Rx | c2sl I49()-Rx |
354. | Hexacosanal-Rx | C26H51O-Rx |
355. | Heptacosanal-Rx | C27H53O-Rx |
356. | Octacosanal-Rx | C28H55O-Rx |
357. | Triacontanal-Rx | C3oH590-Rx |
358. | Dotriacontanal-Rx | C32H63O-Rx |
[0064] Additional deuterium-enriched aldehydes of the present invention include aldehydes 65358 listed in the Tables B-L below.
[0065] Table B: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 2% of the hydrogen atoms present in Rx.
[0066] Table C: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 10% of the hydrogen atoms present in Rx.
[0067] Table D: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 20% of the hydrogen atoms present in Rv
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0068] Table E: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 30% of the hydrogen atoms present in Rx, [0069] Table F: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 40% of the hydrogen atoms present in Rx.
[0070] Table G: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 50% of the hydrogen atoms present in Rx.
[0071] Table H: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 60% of the hydrogen atoms present in Rx, [0072] Table I: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 70% of the hydrogen atoms present in Rx.
[0073] Table J: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 80% of the hydrogen atoms present in Rx, [0074] Table K: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 90% of the hydrogen atoms present in Rx.
[0075] Table L: Examples 64-358 of Table A, except that the deuterium isotope in Rx is in an amount greater than 95% of the hydrogen atoms present in Rx, [0076] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table A, [0077] Reference to “compositions comprising compounds 65-358” means compositions comprising at least 6x10 molecules of at least one of aldehydes 65-358, typically at least 6 x 1019 molecules, and may, for example, comprise at least 6 x 10° molecules, 6 x 10“' molecules, x 10 molecules, or 6 x 1023 molecules. Rx is hydrogen, wherein the deuterium isotope is in an amount greater than 0.10 percent of the Rx hydrogen atoms. In certain cases, the deuterium
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 isotope comprises greater than 1% of the hydrogen atoms, or even greater than 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% of the hydrogen atoms, [0078] In another aspect, reference to “compositions comprising compounds 65-358” means compositions comprising at least 0,1 mole of at least one of aldehydes 65-358. Compositions of the invention may, for example, comprise at least 0,2, 0,5, 1, 2, 3, 4, 5, 10, to 20 moles of at least one of compounds 65-358.
[0079] In another aspect, reference to “compositions comprising compounds 65-358” means compositions comprising at least I gram of at least one of aldehydes 65-358. Compositions of the invention may, for example, comprise at least 5, 10, 20, 30, 40, 50, 100, 500, to 1,000 grams of at least one of compounds 65-358.
[0080] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table B.
[0081] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table C, [0082] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table D.
[0083] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table E, [0084] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table F, [0085] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table G.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0086] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table H, [0087] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table I.
[0088] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table J.
[0089] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table K, [0090] In another aspect, the present invention provides a composition, comprising: a deuterium-enriched aldehyde selected from aldehydes 65-358 of Table L.
[0091] Compounds of the present invention are more stable to autoxidation than the corresponding aldehydes where the hydrogen atom attached to the carbonyl moiety (i.e., HC(O)) is not enriched in the deuterium isotope. For instance, where the deuterium isotope comprises greater than 90 percent of the subject hydrogen atoms, the rate of autoxidation - i.e., conversion of the aldehyde to its corresponding carboxylic acid through oxidation by atmospheric oxidation in the absence of an oxidation catalyst (e.g., metal or transition metalbased catalyst) - is reduced by at least 10 percent (e.g., if 10.0 percent of the aldehyde without deuterium enrichment experiences autoxidation, less than 9.0 percent of the aldehyde with deuterium enrichment experiences autoxidation under the same conditions). In certain cases, the rate is reduced by at least 20 percent, 30 percent, 40 percent, 50 percent, 60 percent, 70 percent, percent or 90 percent.
[0092] Compounds 1-358 can be synthesized using any appropriate method. Examples of such methods include: reduction of the cones ponding acid halide with deuterium gas (see USP
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
5,149,820); reduction of the corresponding tertiary amide using CpzZriDjCl (see Georg et al.
Tet. Lett. 2004; 45: 2787-2789); and, reduction of the corresponding ester using L1AID4 to produce an alcohol and subsequent oxidation (see Kim et al., J. Label Compd Radiopharm 2004;
47: 921-934)(or just oxidation of a corresponding alcohol);
[0093] Alternatively, an additional method includes reduction of the un-enriched aldehyde with NaBD4 or NaCNBD3 followed by re-oxidation with pyridinium chlorochromate or another suitable oxidant, in which the deuterium enrichment of the aldehyde is a result of the isotope effect, [0094] In another aspect, the present invention provides compositions comprising one or more of aldehydes 1-64 and an organic solvent (e.g., an alcohol (e.g., ethyl alcohol and isopropyl alcohol), ether (e.g., dimethyl ethyl), or alkane (e.g., hexanes)). In another aspect, the organic solvent is ethyl alcohol. Examples of the concentration of the ethyl alcohol include 50-97.5 weight percent, 60-97 weight percent, and 70-96 weight percent.
[0095] In another aspect, the present invention provides compositions comprising one or more of aldehydes 65-358 and an organic solvent (e.g., an alcohol (e.g., ethyl alcohol and isopropyl alcohol), ether (e.g., dimethyl ethyl), or alkane (e.g., hexanes)). In another aspect, the organic solvent is ethyl alcohol. Examples of the concentration of the ethyl alcohol include 50-97.5 weight percent, 60-97 weight percent, and 70-96 weight percent, [0096] In another aspect, the compositions of the present invention comprise an additional ingredient. Examples of additional ingredients include: dipropylene glycol; isopropyl myristate;
oils (e.g., coconut oil); and liquid waxes (e.g., jojoba oil).
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [0097] The compositions discussed herein also can be used, for example, in a perfume. Reference to “perfume” means a mixture comprising fragrant compounds and solvents used to give the human body, animals, objects and living spaces a pleasant scent.
[0098] In another aspect, the present invention provides novel compositions for modulating the behavior of insects (e.g., attracting or inhibiting insect species), comprising: a deuteriumenriched aldehyde selected from structures 1-64, wherein the aldehyde is a pheromone and an optional additional component or components suitable for the composition (e.g., a pesticide, dispensing material or device, solvent, adhesive capable of trapping the insect, etc,).
[0099] In another aspect, the present invention provides novel compositions for modulating the behavior of insects (e.g., attracting or inhibiting insect species), comprising: a deuteriumenriched aldehyde selected from structures 65-358, wherein the aldehyde is a pheromone and an optional additional component or components suitable for the composition (e.g., a pesticide, dispensing material or device, solvent, adhesive capable of trapping the insect, etc.).
[00100] In another aspect, the composition comprises a pheromone blend.
[00101] A pheromone blend, comprises: at least one pheromone aldehyde selected from the deuterium-enriched aldehydes of the present invention and at least one additional pheromone that is either an un-enriched aldehyde or a different pheromone aldehyde selected from the deuterium-enriched aldehydes of the present invention.
[00102] In another aspect, the present invention provides novel methods for modulating the behavior of insects (e.£., attracting insect species or inhibiting the mating or aggregation of insect species), comprising:
a. applying a deuterium-enriched aldehyde pheromone of the present invention. Or a composition comprising a deuterium-enriched aldehyde pheromone of the present
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 invention and a optionally a solvent or other additional component suitable for the composition, to a surface of an object (e.g., a lure within a trap wherein the insect enters but cannot leave, a lure or trap wherein the insect sticks to a surface of the trap, or a lure or trap containing a chemical capable of killing the insect); and,
b. placing the object in a location where one desires either to attract insect species or inhibiting the mating or aggregation of insect species.
[00103] In another aspect, a pheromone blend is applied (either neat or as a part of a composition of the present invention), [00104] In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are applied (either neat or as a part of a composition ofthe present invention).
[00105] Alternatively, the method comprises: distributing a composition comprising a deuterium-enriched aldehyde pheromone of the present invention into an area (e.g,, by aerial spraying over crops), into a stored product (e.g., traps or disruptant dispensers in grain crops), onto vegetation (e.g., by manual application of dollops of an emulsion (e.g., SPLAT® type formulation) onto plants, vines, leaves, or shoots), or by applying by aerial dissemination or manual placement a composition of pheromone-impregnated chips, pheromone containing polymer hollow fibers, or pheromone containing rubber septa, in order to modulate the behavior of insects by disruption of mating behavior. More than one composition or method may be combined to achieve the desired reduction of crop damage.
[00106] In another aspect, a pheromone blend is present in the distributed composition.
[00107] In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are present in the distributed composition.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00108] In another aspect, the deuterium-enriched aldehyde pheromone of the present invention is distributed impregnated on a chip, in a polymer hollow fiber, or adsorbed within a rubber septum.
[00109] In another aspect, a pheromone blend is distributed impregnated on a chip, in a polymer hollow fiber, or adsorbed within a rubber septum.
[00110] In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are distributed impregnated on a chip, in a polymer hollow fiber, or adsorbed within a rubber septum, [00111] The modulation of insect behavior can comprise attraction to an aldehyde pheromone trap, or alternatively, disruption of mate-finding and mating behavior, A benefit of such insect behavior modulation can be diminished crop damage, such as reducing damage to fruits, nuts, seeds, grains, grapes, leaves, shoots, bark, grain, or other valuable crops by reducing insect damage to said crop, whether in the field or in storage after harvesting said valuable crop.
[00112] In another aspect, the modulating composition of the present invention, comprises: a deuterium-enriched aldehyde pheromone of the present invention formulated to be used in an attractant trap (an attractant composition), [00113] In another aspect, the modulating composition of the present invention, comprises: a pheromone blend formulated to be used in an attractant trap (an attractant composition).
[00114] In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are present in the modulating composition.
[00115] In another aspect, the present invention provides a method of using an attractant composition in an attractant trap.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00116] In another aspect, the present invention provides a method of using a deuteriumenriched aldehyde pheromone as a component of a composition to attract, trap, or monitor adult insects in a stored product with the goal of minimizing crop product infestation and loss. In another aspect, a pheromone blend is in the composition. In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are present in the composition.
[00117] In another aspect, the modulating composition of the present invention, comprises a deuterium-enriched aldehyde pheromone of the present invention formulated to be used as a mating disruptant (a disruptant composition). A disruptant composition is typically dispersed throughout part or all of an area to be protected, [00118] In another aspect, a pheromone blend is present in the disruptant composition.
[00119] In another aspect, two or more deuterium-enriched aldehyde pheromones of the present invention are present in the disruptant composition.
[00120] In another aspect, the present invention provides a method of using a disruptant composition in an area to be protected (e.g., a crop field). It will be understood by those skilled in the art that dismption of mating by adult insects will reduce the population of offspring.
Frequently it is the offspring, or larvae, of the species that are responsible for damage to the field crop or harvested crop product, A skilled person will understand that disruption of mating may be an indirect method of reducing damage to field crops or harvested crop products by larval forms of the insects that feed on the crop or crop product.
[00121] In another aspect, the disruptant composition is made using an oil/water emulsion preparation to deposit the disruptant onto a carrier. Examples of carriers include a polymeric hollow loop, a rubber (e.g., septum) or polymeric earner, and impregnable chips.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00122] Examples of types of attractant and/or disruptant formulations include: microencapsulation, hollow tube dispensers, bait stations, oil-water emulsions, and other volatile deuterium-enriched aldehyde dispensers.
[00123] Microencapsulation refers to encapsulating at least one deuterium-enriched aldehyde pheromone of the present invention in a polymer. The polymer is selected to delay the release of the pheromone for at least a few days. The microencapsulated pheromone(s) can be applied by spraying.
[00124] Examples of hollow tube dispensers include plastic twist-tie type dispensers, plastic hollow fibers, and plastic hollow microfibers. These types of dispensers are filled with at least one disruptant or a disruptant composition of the present invention and then distributed throughout the area to be protected.
[00125] Bait stations are stationary devices that are typically used to attract and kill.
Examples include platforms comprising at least pheromone aldehyde of the present invention and a glue board (or some other mechanism capable of trapping the attracted insect). Instead of or in addition to glue, the station can contain a pesticide that negatively affects the insect (e.g., reduces its ability to mate or reproduce), [00126] Dispensers or high-emission dispensers are devices that either passively or actively release a pheromone aldehyde of the present invention. Examples of passive release include pheromone sachets or an emulsion (e.g., a SPLAT® (Specialized Lure And Pheromone Technology) formulation). Active dispensers may release bursts of at least one pheromone aldehyde of the present invention (or composition containing at least one pheromone aldehyde of the present invention) at timed intervals or by continuous release through volatilization from the dispenser.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00127] As used herein, a pheromone is a deuterium-enriched aldehyde of structure 1 that has the traits of a natural pheromone, i,e., a chemical capable communicating with at least one insect species. Pheromones may act as alarm signals, provide trails to food sources, attract parasitoids or other predators, and/or attract insects of the same species for the purpose of mating.
[00128] Unless otherwise specified, when a pheromone is recited in the present invention it can be a single deuterium-enriched aldehyde of structure 1 or a blend of pheromones wherein at least one is a deuterium-enriched aldehyde of structure 1. The second, third, fourth, fifth, or more pheromone can be a deuterium-enriched aldehyde of structure 1 or a non-deuteriumenriched aldehyde [00129] In another aspect, a composition of the present invention, comprises: 2, 3,4, 5, 6, 7, 8, 9, or 10 deuterium-enriched aldehyde pheromones of the present invention, [00130] In another aspect, a composition of the present invention, comprises: 2 or more deuterium-enriched aldehyde pheromones of the present invention.
[00131] In another aspect, a composition of the present invention, comprises: 3 or more deuterium-enriched aldehyde pheromones of the present invention, [00132] In another aspect, a composition of the present invention, comprises: 4 or more deuterium-enriched aldehyde pheromones of the present invention, [00133] In another aspect, a composition of the present invention, comprises: 5 or more deuterium-enriched aldehyde pheromones of the present invention.
[00134] In another aspect, a composition of the present invention, comprises: at least 1, 2,
3, 4, Or 5 deuterium-enriched aldehyde pheromones of the present invention and at least 1, 2, 3,
4, or 5 un-enrichedun-enriched pheromones.
WO 2014/145325
PCT/US2014/630065
2018208670 25 Jul 2018 [00135] In another aspect, a composition of the present invention, comprises: at least 1 deuterium-enriched aldehyde pheromone of the present invention and at least 1 un-enriched pheromone.
[00136] In another aspect, a composition of the present invention, comprises: at least 2 deuterium-enriched aldehyde pheromones of the present invention and at least 1 un-enriched pheromone.
[00137] In another aspect, a composition of the present invention, comprises: at least 1 deuterium-enriched aldehyde pheromones of the present invention and at least 2 un-enriched pheromones.
[00138] In another aspect, a composition of the present invention, comprises: at least 3 deuterium-enriched aldehyde pheromones of the present invention and at least 1 un-enriched pheromone, [00139] In another aspect, a composition of the present invention, comprises: at least 3 deuterium-enriched aldehyde pheromones of the present invention and at least 2 un-enriched pheromones.
[00140] In another aspect, a composition of the present invention, comprises: at least 3 deuterium-enriched aldehyde pheromones of the present invention and at least 3 un-enriched pheromones.
[00141] Examples of insects for which a deuterium-enriched pheromone (or pheromones) can be prepared include: corn earworm (Heliothis (Helicoverpa) zea), tobacco budworm (Heliothis virescens), cotton bollworm (Heliothis (Helicoverpa) armigera), horse chestnut leaf miner (Cameraria orhidella), eastern spruce budworm (Chorisioneura fumiferana), rice borer (Chilo suppressalis), grain weevils (Trogoderma spp.), grain/flower weevils (Triholium spp.),
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 cotton boll weevil (Anthonomus grandis), citrus leaf miner (Phvllocnistis citrella), carob moth (Ectomyelois ceratoniae), and Asian longhorn beetle (Atioplophom glabripetinis), among many others. A complete listing of aldehyde pheromones of insects and the target species using the pheromones is available on the Pherobase.com data base and is hereby incorporated in totality into this application (http://www.pheiObase.com/database/compound/compounds-aldes.php). One or more of the known aldehydic pheromones for these insects can be replaced by a deuterium-enriched aldehyde of the present invention.
[00142] For example, a pheromone composition for the corn earworm containing Z1116:Ald can be replaced with compound 27 of the present invention. Representative examples of such deuterium-enriched aldehyde pheromones include compounds selected from: aldehydes 8,
15, 23, 24, 27, 28, 29, 30,34, 35,36, 37,38, 39,40, 41,42, 43,44, 45, 46, 47,48, 49, 50, 51,52,
53,54, 55,56, 57,58, 59,60, 61,62, 63, and 64.
[00143] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is selected from: aldehydes 27, 28, and
35.
[00144] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is selected from: aldehydes 27 and 28. [00145] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 36,
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00146] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is selected from: aldehydes 37 and 38. [00147] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is selected from: aldehydes 27, 28. and
44.
[00148] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that Is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 49.
[00149] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 55.
[00150] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 59.
[00151] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is selected from: aldehyde 40, 60, and
61.
[00152] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 62.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00153] In another aspect, the present invention provides novel compositions for modulating the behavior of insects, comprising: at least one deuterium-enriched aldehyde that is a pheromone, wherein the deuterium-enriched aldehyde is: aldehyde 64.
[00154] Compounds of the present invention are also more stable to autoxidation than their corresponding non-deuterium enriched counterpails when included in compositions of the present invention. The rate of auto oxidation is reduced by at least 10 percent. In certain cases, the rate is reduced by at least 20 percent, 30 percent, 40 percent, 50 percent, 60 percent, 70 percent, 80 percent or 90 percent, [00155] The skilled person will recognize that pheromones or pheromone blends for a given species may include non-aldehyde components, such as an alkyl, alkenyl, alkynyl alcohol or an alkyl, alkenyl or alkynyl ester. When the blend for optimal attraction includes such an additional non-aldehyde component, the skilled person would augment the deuterium-labeled pheromone of the present invention with the additional attractant or disruptant compound that increases the efficacy of modulation of the insect behavior, e.g., mating disruption or attraction to a trap.
WO 2014/145325
PCT/US2014/030065 [00156] In Table 1 are described examples of compositions of the present invention:
2018208670 25 Jul 2018
wherein:
there are at least 6x10 molecules of the aldehyde present in the composition;
Rx is hydrogen, wherein the deuterium isotope is present in an amount greater than 0.10% of the Rx hydrogen atoms;
unless otherwise defined, R|, R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heteroalkyl, substituted heteroalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl; alternatively, the CRjR3R3 moiety forms a group selected from: an aryl, substituted aryl, heteroaryl, and substituted heteroaryl;
alternatively, the CR|R2 moiety forms a group a group selected from: an alkenyl and substituted alkenyl;
alternatively, the CRiR2R3 moiety forms a group a group selected from: an alkynyl and substituted alkynyl; and, optionally, the aldehyde is substituted with C(O)Ry, wherein Rx is hydrogen, wherein the deuterium isotope is present in an amount greater than 0.10% of the Ry hydrogen atoms.
[00157] Table 1:
Structure #
Solvent (weight%)
Ex.#
Ri, R2, R
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
A. | 1 | As defined | Ethyl alcohol 70-96% by weight |
B. | 1 | one of Ri, R2 and Iff is alkyl | Ethyl alcohol 70-96% by weight |
C. | 1 | one of Rj, R2 and R_i is substituted alkyl | Ethyl alcohol 70-96% by weight |
D. | 1 | one of Rj, R2 and R2 is alkenyl | Ethyl alcohol 70-96% by weight |
E. | 1 | one of R[, R2 and Iff is substituted alkenyl | Ethyl alcohol 70-96% by weight |
F. | 1 | one of R|, R2 and R2 is alkynyl | Ethyl alcohol 70-96% by weight |
G. | 1 | one of R], R2 and R2 is substituted alkynyl | Ethyl alcohol 70-96% by weight |
H. | 1 | one of Rj, R2 and R3 is heteroalkyl | Ethyl alcohol 70-96% by weight |
I. | 1 | one of Ri, R2 and Iff is substituted heteroalkyl | Ethyl alcohol 70-96% by weight |
J. | 1 | one of R,, R2 and R2 is aryl | Ethyl alcohol 70-96% by weight |
K. | 1 | one of R|, R2 and R2 is substituted aryl | Ethyl alcohol 70-96% by weight |
L. | 1 | one of Rj, R2 and R2 is heteroaryl | Ethyl alcohol 70-96% by weight |
M. | 1 | one of R[, R2 and R3 is substituted heteroaryl | Ethyl alcohol 70-96% by weight |
N. | 1 | one of R|, R2 and R2 is alkyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
0. | 1 | one of Rj, R2 and R2 is substituted alkyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
P. | 1 | one of Rj, R2 and R2 is alkenyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
Q. | 1 | one of Ri, R2 and R3 is substituted alkenyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
R. | 1 | one of Ri, R2 and R3 is alkynyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
S. | 1 | one of Ri, R2 and R2 is substituted | Ethyl alcohol |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
alkynyl and another is hydrogen | 70-96% by weight | ||
T. | 1 | one of R], R2 and R2 is heteroalkyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
u. | 1 | one of Rj, R2 and R> is substituted heteroalkyl and another is hydrogen | Ethyl alcohol 70-96% by weight |
V. | 1 | one of Ri, R2 and R2 is aryl and another is hydrogen | Ethyl alcohol 70-96% by weight |
w. | 1 | one of R|, R2 and R2 is substituted aryl and another is hydrogen | Ethyl alcohol 70-96% by weight |
X. | 1 | one of R|, R2 and R2 is heteroaryl and another is hydrogen | Ethyl alcohol 70-96% by weight |
Y. | 1 | one of Rj, R2 and R2 is substituted heteroaryl and another is hydrogen | Ethyl alcohol 70-96% by weight |
z. | 1 | Ri, R2 and R, is alkyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
AA. | 1 | one of R|, R2 and R2 is substituted alkyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
BB. | 1 | one of Rj, R2 and Ri is alkenyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
CC. | 1 | one of Rj, R2 and R3 is substituted alkenyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
DD. | 1 | one of Rj, R2 and R3 is alkynyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
EE. | 1 | one of Rj, R2 and R2 is substituted alkynyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
FF. | 1 | one of Rj, R2 and R2 is heteroalkyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
GG. | 1 | one of Rj, R2 and R3 is substituted heteroalkyl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
HH. | 1 | one of Ri, R2 and IT is aryl and the other two hydrogen | Ethyl alcohol 70-96% by weight |
II. | 1 | one of R[, R2 and R3 is substituted aryl the other two are hydrogen | Ethyl alcohol 70-96% by weight |
JJ. | 1 | one of R1, R2 and R2 is heteroaryl and the other two are hydrogen | Ethyl alcohol 70-96% by weight |
KK. | 1 | one of R], R2 and R2 is substituted heteroaryl and the other two are | Ethyl alcohol |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
hydrogen | 70-96% by weight | ||
LL. | 1 | CR1R2R3 is aryl | Ethyl alcohol 70-96% by weight |
MM. | 1 | CRjRiRi is substituted aryl | Ethyl alcohol 70-96% by weight |
NN. | 1 | CR1R2R3 is heteroaryl | Ethyl alcohol 70-96% by weight |
OO. | 1 | CR1R2R3 is substituted heteroaryl | Ethyl alcohol 70-96% by weight |
PP. | 1 | CR|Ri alkenyl and Ri is hydrogen | Ethyl alcohol 70-96% by weight |
QQ. | 1 | CR]R2 substituted alkenyl and R3 is hydrogen | Ethyl alcohol 70-96% by weight |
RR. | 1 | CR1R2 alkenyl and R3 is alkyl | Ethyl alcohol 70-96% by weight |
SS. | 1 | CR1R2 substituted alkenyl and R; is alkyl | Ethyl alcohol 70-96% by weight |
TT. | 1 | R] is alkyl substituted with C(O)Ry | Ethyl alcohol 70-96% by weight |
UU. | 1 | R] is alkyl substituted with C(O)Ry and Ri and R-, are hydrogens | Ethyl alcohol 70-96% by weight |
vv. | 1 | CR1R2R3 is aryl substituted with C(O)Ry | Ethyl alcohol 70-96% by weight |
ww. | 1 | CR]R2R3 is substituted aryl substituted with C(O)Ry | Ethyl alcohol 70-96% by weight |
XX. | 2 | Ethyl alcohol 70-96% by weight | |
YY. | 3 | - | Ethyl alcohol 70-96% by weight |
zz. | 4 | - | Ethyl alcohol 70-96% by weight |
AAA. | 5 | - | Ethyl alcohol 70-96% by weight |
BBB. | 6 | - | Ethyl alcohol 70-96% by weight |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
ccc. | 7 | - | Ethyl alcohol 70-96% by weight |
DDD. | 8 | - | Ethyl alcohol 70-96% by weight |
EEE. | 9 | - | Ethyl alcohol 70-96% by weight |
FFF. | 10 | - | Ethyl alcohol 70-96% by weight |
GGG. | 11 | - | Ethyl alcohol 70-96% by weight |
HHH. | 12 | - | Ethyl alcohol 70-96% by weight |
III. | 13 | - | Ethyl alcohol 70-96% by weight |
JJJ. | 14 | - | Ethyl alcohol 70-96% by weight |
KKK. | 15 | - | Ethyl alcohol 70-96% by weight |
LLL. | 16 | - | Ethyl alcohol 70-96% by weight |
MMM. | 17 | - | Ethyl alcohol 70-96% by weight |
NNN. | 18 | - | Ethyl alcohol 70-96% by weight |
000. | 19 | - | Ethyl alcohol 70-96% by weight |
PPP. | 20 | - | Ethyl alcohol 70-96% by weight |
QQQ- | 21 | - | Ethyl alcohol 70-96% by weight |
RRR. | 22 | - | Ethyl alcohol |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
70-96% by weight | |||
sss. | 23 | - | Ethyl alcohol 70-96% by weight |
TTT. | 24 | - | Ethyl alcohol 70-96% by weight |
uuu. | 25 | - | Ethyl alcohol 70-96% by weight |
vvv. | 26 | - | Ethyl alcohol 70-96% by weight |
WWW. | 27 | - | Ethyl alcohol 70-96% by weight |
XXX. | 28 | - | Ethyl alcohol 70-96% by weight |
YYY. | 29 | - | Ethyl alcohol 70-96% by weight |
zzz. | 30 | * | Ethyl alcohol 70-96% by weight |
AAAA. | 31 | - | Ethyl alcohol 70-96% by weight |
BBBB. | 32 | - | Ethyl alcohol 70-96% by weight |
CCCC. | 33 | - | Ethyl alcohol 70-96% by weight |
DDDD. | 34 | - | Ethyl alcohol 70-96% by weight |
EEEE. | 35 | - | Ethyl alcohol 70-96% by weight |
FFFF. | 36 | - | Ethyl alcohol 70-96% by weight |
GGGG. | 37 | - | Ethyl alcohol 70-96% by weight |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
HHHH. | 38 | - | Ethyl alcohol 70-96% by weight |
IIII. | 39 | - | Ethyl alcohol 70-96% by weight |
JJJJ. | 40 | - | Ethyl alcohol 70-96% by weight |
KKKK. | 41 | - | Ethyl alcohol 70-96% by weight |
LLLL. | 42 | - | Ethyl alcohol 70-96% by weight |
MMMM. | 43 | - | Ethyl alcohol 70-96% by weight |
NNNN. | 44 | - | Ethyl alcoho) 70-96% by weight |
0000. | 45 | - | Ethyl alcohol 70-96% by weight |
PPPP. | 46 | - | Ethyl alcohol 70-96% by weight |
QQQQ. | 47 | - | Ethyl alcohol 70-96% by weight |
RRRR, | 48 | - | Ethyl alcohol 70-96% by weight |
SSSS. | 49 | - | Ethyl alcohol 70-96% by weight |
tttt. | 50 | - | Ethyl alcohol 70-96% by weight |
UUUU. | 51 | - | Ethyl alcohol 70-96% by weight |
VVVV. | 52 | - | Ethyl alcohol 70-96% by weight |
WWWW. | 53 | - | Ethyl alcoho) |
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018
70-96% by weight | |||
xxxx. | 54 | - | Ethyl alcohol 70-96% by weight |
YYYY. | 55 | - | Ethyl alcohol 70-96% by weight |
//././. | 56 | - | Ethyl alcohol 70-96% by weight |
AAAAA. | 57 | - | Ethyl alcohol 70-96% by weight |
BBBBB. | 58 | - | Ethyl alcohol 70-96% by weight |
CCCCC. | 59 | - | Ethyl alcohol 70-96% by weight |
DDDDD. | 60 | - | Ethyl alcohol 70-96% by weight |
EEEEE. | 61 | * | Ethyl alcohol 70-96% by weight |
FFFFF. | 62 | - | Ethyl alcohol 70-96% by weight |
GGGGG. | 63 | - | Ethyl alcohol 70-96% by weight |
HHHHH. | 64 | - | Ethyl alcohol 70-96% by weight |
[00158] Table 2: Examples A-HHHHH of Table 2 correspond to examples A-HHHHH of Table 1, except that the deuterium isotope in Rx is in an amount greater than 2% of the hydrogen atoms present in Rx, [00159] Table 3: Examples A-HHHHH of Table 2 correspond to examples A-HHHHH of Table 1, except that the deuterium isotope in Rx is in an amount greater than 10% of the hydrogen atoms present in Rx.
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 [00160] Table 4: Examples A-HHHHH of Table 2 correspond to examples A-HHHHH of Table 1, except that the deuterium isotope in Rx is in an amount greater than 50% of the hydrogen atoms present in Rx.
[00161] Table 5: Examples A-HHHHH of Table 2 correspond to examples A-HHHHH of Table 1, except that the deuterium isotope in Rx is in an amount greater than 90% of the hydrogen atoms present in Rx.
[00162] In another aspect, compounds according to the present invention can be used to make resins and/or polymers. The method comprises the steps of: mixing a deuterium-enriched aldehyde selected from structures 1-64 with an aromatic compound (i.e., aryl-containing compound) or an olefinic compound (i.e., alkenyl-containing compound) in a solvent and in the presence of a catalyst, in such a way as to initiate a reaction between the aromatic or olefinic compound and the aldehyde; and, isolating the reaction product (e.g., resin or polymer) resulting from the reaction. The catalyst may be a Bronsted acid (e.g., aqueous sulfuric or hydrochloric acid), a Lewis acid (e.g., AlCfi), a base (e.g., KOH) or a metal (e.g., transition metal). The reaction may be earned out at room temperature or at elevated temperature (e.g., 50 °C, 60 °C, 70 °C, 80 °C, 90 °C, 100 °C, 110 °C or 120 °C), The reaction may also be carried out at atmospheric pressure or at elevated pressure (e.g., 2 atm, 3 atm, 4 atm or 5 atm).
[00163] In another aspect, compounds according to the present invention can be used to make resins and/or polymers. The method comprises the steps of: mixing a deuterium-enriched aldehyde selected from structures 65-358 with an aromatic compound (i.e., aryl-containing compound) or an olefinic compound (i.e., alkenyl-containing compound) in a solvent and in the presence of a catalyst, in such a way as to initiate a reaction between the aromatic or olefinic compound and the aldehyde; and, isolating the reaction product (e.g., resin or polymer) resulting
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 from the reaction. The catalyst may be a Bronsted acid (e.g., aqueous sulfuric or hydrochloric acid), a Lewis acid (e.g., A1C13), a base (e.g., KOH) or a metal (e.g., transition metal). The reaction may be carried out at room temperature or at elevated temperature (e.g., 50 °C, 60 °C, 70 °C, 80 °C, 90 °C, 100 °C, 110 °C or 120 °C), The reaction may also be carried out at atmospheric pressure or at elevated pressure (e.g., 2 atm, 3 atm, 4 atm or 5 atm).
[00164] The rate of autoxidation of aldehydes in the polymerization/resin producing reaction is reduced by at least 10 percent as compared to use of non-deuterium enriched aldehydes under the same conditions. In certain cases, the rate is reduced by at least 20 percent, percent, 40 percent, 50 percent, 60 percent, 70 percent, 80 percent or 90 percent.
[00165] The following general methods of making a resin and/or polymer are meant to illustrate, not limit, the present invention.
[00166] General Method 1 [00167] An aromatic compound (e.g., naphthalene, benzene, substituted benzene such as toluene) is heated in an acidic mixture (e.g., sulfuric acid and water) for 6 horn’s at 160 °C. The mixture is cooled to 100 °C, and a deuterium-enriched aldehyde selected from structures 1-64 is added in an amount that is less than a molar equivalent of the aromatic compound. The resulting mixture is kept at 100 °C at a time period ranging from 30 minutes to 16 hours to afford a condensation polymer, [00168] General Method IA [00169] An aromatic compound (e.g., naphthalene, benzene, substituted benzene such as toluene) is heated in an acidic mixture (e.g., sulfuric acid and water) for6 hours at 160 °C. The mixture is cooled to 100 °C, and a deuterium-enriched aldehyde selected from structures 65-358 is added in an amount that is less than a molar equivalent of the aromatic compound. The
WO 2014/145325
PCT/US2014/030065
2018208670 25 Jul 2018 resulting mixture is kept at 100 °C at a time period ranging from 30 minutes to 16 hours to afford a condensation polymer, [00170] General Method 2 [00171] To a mixture of a deuterium-enriched aldehydes selected from structures 1-64 and an aromatic alcohol (e.g., resorcinol) at room temperature is added an acidic solution (e.g., aqueous HCI), This affords a condensation polymer upon isolation, [00172] General Method 2B [00173] To a mixture of a deuterium-enriched aldehydes selected from stiuctures 65-358 and an aromatic alcohol (e.g., resorcinol) at room temperature is added an acidic solution (e.g., aqueous HCI), This affords a condensation polymer upon isolation, [00174] General Method 3 [00175] To an aromatic alcohol (e.g., phenol, resorcinol) in an organic solvent (e.g., ether such as dioxane) is slowly added acid (e.g., sulfuric acid). A deuterium-enriched aldehyde selected from structures 1-64 is added dropwise with stirring. The reaction mixture is heated and the contents refluxed for 2 hours. The organic solvent and water are removed, and the reaction mixture is cooled. Precipitation of material provides the condensation polymer, [00176] General Method 3A [00177] To an aromatic alcohol (e.g., phenol, resorcinol) in an organic solvent (e.g., ether such as dioxane) is slowly added acid (e.g., sulfuric acid). A deuterium-enriched aldehyde selected from structures 65-358 is added dropwise with stirring. The reaction mixture is heated and the contents refluxed for 2 hours. The organic solvent and water are removed, and the reaction mixture is cooled. Precipitation of material provides the condensation polymer, [00178] General procedure for measurement of aldehyde oxidations
WO 2014/145325
PCT/US2014/030065
Claims (16)
- WHAT IS CLAIMED IS:1. A composition, comprising: a deuterium-enriched aldehyde of structure 1:2018208670 25 Jul 2018 wherein:there are at least 6 x 1018 molecules of the aldehyde in the composition;Rx is hydrogen, wherein the deuterium isotope is present in an amount greater than 0.10% of theRx hydrogen atoms;Rj, R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heteroalkyl, substituted heteroalkyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl;alternatively, the CR|R2R3 moiety ton ns a group selected from: an aryl, substituted aryl, heteroaryl, and substituted heteroaryl;alternatively, the CR[R2 moiety forms a group a group selected from: an alkenyl and substituted alkenyl;alternatively, the CR[R2R3 moiety forms a group a group selected from: an alkynyl and substituted alkynyl; and, optionally, the aldehyde is substituted with C(O)Ry, wherein Ry is hydrogen, wherein the deuterium isotope is optionally present in an amount greater than 0.10% of the RyWO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018 hydrogen atoms, provided that R , is optionally H when the deuterium isotope is present in an amount greater than 0,10% of the Ry hydrogen atoms.
- 2, The composition according to claim 1, wherein the deuterium-enriched aldehyde is selected from aldehydes 2-64:WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018AWO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018 ,RxWO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018
- 3, The composition according to claim 1, wherein the deuterium-enriched aldehyde is selected from aldehydes 65-358:
Ex. Name 65. Formaldehyde-Rx 66. 2-Methyl-2-pro penal-Rx 67. 2-Methylpropanal-Rx 68. 2-Propenal-Rx 69. 2-Butenal-Rx 70. 2-Methyl-2-butenal-Rx 71. 2-Methylenebutanal-Rx 72. 3-Methyl-2-butenal-Rx 73. 3-Methyl-3-butenal-Rx 74. 3-Methylbutanal-Rx 75. (E)-2~Pentenal-Rx 76. 2-Methylenepentanal-Rx 77. 2-Pentenal-Rx 78. 3-Methyl-l-(vinyloxy)-butane-Rx 79. 4-Methylpentanal-Rx 80. Furan-2-carbaldehyde-Rx 81. (E)-2-Hexenal-Rx 82. (E)-4-oxo-2-Hexenal-Rx 83. (E,E)-2,4-Dimethyl-2,4-hexadienal-Rx 84. (E,E)-2,4-Hexadienal-Rx 85. (Z)-2-Hexenal-Rx 86. (Z)-3-Hexenal-Rx 87. (Z)-4-oxo-2-Hexenal-Rx 88. 1-Hexenal-Rx 89. 2,3-Dihydrox ybenzaldeh yde-Rx 90. 2-Hexenal-Rx 91. 3-((E)-2-Hexenoxy)-hexanal-Rx 92. 3,5 -Dimethy lhex anal-Rx 93. 3-Ethoxyhexanal-Rx 94. 3-H ydroxybenzaldeh yde-Rx 95. 3-Hydroxyhexanal-Rx 96. 4- Hydroxy-3,5 -dimethox ybenzaldeh yde- Rx 97. 4-Hydroxybenzaldehyde-Rx 98. 5-Methylhexanal-Rx 99. Hexanal-Rx 100. (1R,2S,5S)-Iridodial-Rx 101. (lR,5S)-6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde-Rx 102. (IS, 2 R,3S )-2-(1 -Form ylviny 1)-5 -methylcyclopentanecarbaldehyde-Rx 103. (3S,8R)-2-Methyl-5-( 1 -formylethyl)-1-cyclopentene-1 -carbaldehyde-Rx WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018104. (3 S,8 S )-2-Methy 1-5-( 1-formylethy 1)-1-eye lopentene-l-carbaldehyde-Rx 105. {5S,8S)-2-Methyl-5-( 1 -formylethyl)-1 -cyclopentene-1 -carbaldehyde-Rx 106. (E)-2-(2-Hydroxyethyl )-6-methy 1-2,5-heptadienal-Rx 107. (E)-2-(2-Hydroxyethylidene)-6-methyl-5-heptenal-Rx 108. (E)-2-Heptenal-Rx 109. (E)-2-Isopropyl-5 -meth y 1 -2-hexenal- Rx 110. (E,Z)-2,4-Heptadienal-Rx 111. (R)-2-(( 1 R,2R,3S)-3-Methyl-2-vinylcyclopentyl)-propanal-Rx 112. (R)-2-(( 1 S,2S,3S)-3-Methyl-2-vinylcyclopentyl)-propanal-Rx 113. (R)-2,6-Di methyl-5-heptenal-Rx 114. (R)-7-Hydroxy-6,7-dihydro-5H-pyiTolizidine-l-carboxaldehyde-Rx 115. (S)-4-(Prop-1 -en-2-yl)-cyclohex-1 -enecarbaldehyde-Rx 116. {S)-7-Hydroxy-6,7-dihydiO-5H-pyrrolizidine-!-carboxaldehyde-Rx 117. (Z)-2-IsopiOpyl-5-methyl -2-hexenal -Rx 118. 1-Formyl-6,7-dihydro-5H-pyiTolizine-Rx 119. 1 -Formyl-7 -hydroxy-6,7-dihydro-5H-pyrrolizine-Rx 120. 2-(3-Methylcyclopenty])-propanal-Rx 121. 2,6-Dimethyl-5-beptenal-Rx 122. 2-Acetyl-5-methylcyclopentanecarbaldehyde-Rx 123. 2-Methoxybenzaldehyde-Rx 124. 2-Methyl-1 -cyclopentenecaj'boxaldehyde-Rx 125. 3,3-Dimethyl-5-oxo-7-oxabjcyclo[4.1,0]heptane-1 -carba)dehyde-Rx 126. 3-Hydroxybenzene-1,2-dicarbaldehyde-Rx 127. 3-Methylbenzaldehyde-Rx 128. 4-(Heptyloxy)-butanal-Rx 129. 4-Methoxybenzaldehyde-Rx 130. 6,7-Dihydro-5H-pyrrolizine-l-carboxaldehyde-Rx 131. 6,7-Dihydro-7-oxo-5H-pyrrolizine-l-carbaldebyde-Rx 132. 6-Methylheptanal-Rx 133. 7-Hydroxy-6,7-dihydro-5 H-pyrroli zin-1 -carboxal dehyde-Rx 134. Benzaldehyde-Rx 135. Cyclohexanedial-Rx 136. Heptanal-Rx 137. Plaaiodial-Rx 138. (lR,2S)-cis-2-Isopropenyl-l-methylcyclobutaneethanal-Rx 139. (1 R,2S,5R,8R)-Iridodial-Rx 140. (4S)-(3-Oxoprop- l-en-2-yl)-cyclohex-l-enecai-baldehyde-Rx 141. (E)-2-(3,3-Di methy icyc 1 ohexylidene)-acetaldehyde- Rx 142. (E)-2-(4-Methyl-3-pentenyl)-butenedial-Rx 143. (E)-2-(4-Meth yl-3-pentenylidene)-butanedial-Rx 144. (E)-2,7-Octadienal-Rx 145. {E)-2-Methyl-5-(3-furyl)-2-pentenal-Rx 146. (E)-2-Octenal-Rx 147. (E)-3,7-Dimethyl-2,6-octadienal-Rx WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018148. (E)-3,7-Dimethyl-2,6-octadienal-Rx 149. (E)-4-oxo-2-Octenal-Rx 150. (E)-7-Methyl-2-octenal-Rx 151. (E,E)-2,4-Octadienal-Rx 152. (E,E)-2,6-Dimethyl-8-hydroxy-2,6-octadienal-Rx 153. (E,E)-2,6-Octadienal-Rx 154. (E,E)-2,6-Octadienedial-Rx 155. (E,Z)-2,4-Octadienal-Rx 156. (E,Z)-2,6-Octadienal-Rx 157. (Z)-2-( 3,3-Dimeth y Icyclohexy lidene)-acetaldehyde-Rx 158. (Z)-3,7-Dimethyl-2,6-octadienal-Rx 159. (Z,E)-3,7-Dimethyl-2,6-octadiena1-Rx 160. 1-Octenal-Rx 161. 2-(1 -Formyl vinyl)-5-methylcyc!opentanecarbaldehyde-Rx 162. 2,6,6-Trimethyl-l-cyclobexene-l-carbaIdehyde-Rx 163. 2-Ethyloctanal-Rx 164. 2-H ydroxy-6- meth y Ibenzaldeh yde-Rx 165. 2-Meth yl benzaldehyde-Rx 166. 2-Octenal-Rx 167. 2-Phen ylpro penal-Rx 168. 3,7-Dimethyl-6-octenal-Rx 169. 3-Ethoxy-4-hydroxybenzaldehyde-Rx 170. 3-Ethyl benzaldehyde-Rx 171. 3-Isopropyl-6-methyl benzaldehyde-Rx 172. 3-Octenal-Rx 173. 3-o xo-4-Isopropyl idene-1 -cyclohexene-1 -carboxya1dehyde-Rx 174. 4-Hydroxy-2-methyl benzaldehyde-Rx 175. 4-Hydroxy-3-methoxybenzaldehyde-Rx 176. 4-Isopropenyl-1 -cyclohexene-1 -carbaldehyde-Rx 177. 4-Isopropenyl-3-oxo-l-cyclohexene-l-carboxyaldehyde-Rx 178. 4-oxo-Octenal-Rx 179. 4S-4-Isopropenyl-3-oxo-1 -cyclohexene-1 -carboxyaldehyde-Rx 180. 6,6-Dimethylbicyclo[3.1. l]hept-2-ene-2-carbaldehyde-Rx 181. 7-Methyloctanal-Rx 182. Anisomorphal-Rx 183. cis-2-Isopropenyl-1 ~methylcyclobutaneethanal~Rx 184. Octanal-Rx 185. PerLiphasmal-Rx 186. (E)-4,8-Nonadienal-Rx 187. (E)-8-Methyl-2-nonenal-Rx 188. (E,E)-2,4-N onadienal-Rx 189. (E,E,E)-2,4,6-Nonatrienal-Rx 190. (E,E,Z)-2,4,6-Nonatrienal-Rx 191. (E,Z)-2,6-Nonadienal-Rx WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018192. (E,Z,Z)-2,4,6-Nonatnenal-Rx 193. {Z)-3-Nonenal-Rx 194. (Z)-4,8-Nonadienal-Rx 195. (Z)-4-Nonenal-Rx 196. (Z)-8-Methyl-2-nonenal-Rx 197. 2-Phenyl-2-butenal-Rx 198. 3-(4- Methoxyphenyl )-2-propenal-Rx 199. 3-Phen yl -2-propenal-Rx 200. 3-Phenylpropanal-Rx 201. 6-Ethyl benzaldehyde-Rx 202. 8-Methylnonanal-Rx 203. 9-Acetyloxynonanal-Rx 204. Nonanal-Rx 205. (E)-2,9-Decadienal-Rx 206. (E)-2-Decenal-R, 207. (E)-4-oxo-2-Decenal-Rx 208. (E)-8-Hydroxy-4,8-d imethyl-4,9-decadienal-Rx 209. (E)-9-Methyl-2-decenal-Rx 210. (E,E)-2,4-Decadienal-Rx 211. (E,Z)-2,4-Decadienal-Rx 212. (Z)-4- Decenal-Rx 213. (Z)-5-Decenal-Rx 214. (Z)-9-Methyl-2-decenal-Rx 215. 1-Decenal-Rx 216. 2-Decenal-Rx 217. 2-Ethyldecanal-Rx 218. Decanal-Rx 219. (5E)-2,6,10-Trimethylundeca-5,9-dienal-Rx 220. (E)-2-Undecenal-Rx 221. (E)-6-Ethyl-2,10-dimethyl-5,9-undecadienal-Rx 222. 10-Undecenal-Rx 223. 2-Butyl-2-octenal-Rx 224. 5-Methyl-2-phenyl-2-hexenal-Rx 225. 8-Iso propyl-5 -meth y 1-3,4,4a,5,6,7,8,8a-octah ydronaphthalene-2-carbaldehyde-Rx 226. syn-4,6-Dimethylundecanal-Rx 227. Undecanal-Rx 228. (3R,5 R,9R )-3,5,9-Tri meth yldodecanal-Rx 229. (3S,6E)-7-Ethyl-3,l l-dimethyldodeca-6,10-dienal-Rx 230. (9R)-3,5,9-T rimethy ldodecanal-Rx 231. (E)-10-Dodecenal-Rx 232. (E)-2-Dodecenal-Rx 233. (E)-3,7,11 -Trimethyl-6,10-dodecadienal-Rx 234. (E)-6- Dodecenal-Rx 235. (E)-7-Dodecenal-Rx WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018236. (E)-8-Dodecenal-Rx 237. {E)-9,l 1-Dodecadjenal-Rx 238. (E)-9-Dodecenal-Rx 239. (E,E)-3,7,1 l-Trimethyl-2,6,10-dodecatrienal-Rx 240. (E,E)-7-Ethyl-3,1 1-dimethyl-2,6,10-dodecatrienal-Rx 241. (E,E )-8,10-Dodecadienal-Rx 242. (E,E,E)-3,7-Dimethyl-8,11 -dioxo-2,6,9-dodecatrienal-Rx 243. (E,E,Z)-3,7-Dimethyl-8,11 -dioxo-2,6,9-dodecatrienal-Rx 244. (E,Z)-5,7-Dodecadienal- Rx 245. (E,Z)-7,9-Dodecadienal-Rx 246. (E,Z)-8,10-Dodecadienal-Rx 247. (S,E)-3,7,1 l-Trimethyl-6,10-dodecadienal-Rx 248. {Z)-2-Methy1-5-((lR,5R,6S)-2,6-dirnethy1bicyclo[3.1,I]hept-2-en-6-yl)-pent-2-enal-Rx 249. (Z)-5-Dodecenal-Rx 250. (Z)-7-Dodecenal-Rx 251. (Z)-9,l 1-Dodecadienal-Rx 252. (Z)-9-Dodecenal-Rx 253. (Z,E)-3,7,! 1-Trimethyl-2,6,10-dodecatrienal-Rx 254. (Z,E)-5,7- Dodecadienal -Rx 255. (Z,E)-7-Ethyl-3,1 l-dimethyl-2,6,10-dodecatrienal-Rx 256. (Z,E)-8,10-Dodecadienal-Rx 257. (Z,Z)-5,7-Dodecadienal-Rx 258. 2~Ethyldodecanal-Rx 259. 3,7,11 -Trimethyl-(E)-6,10-dodecadienal-Rx 260. Dodecanal-Rx 261. syn-4,6-Di methyldod ecanal-Rx 262. (3S,4R,6E, 10Z)-3,4,7,11 -Tetramethyl-6,10-tridecadienal-Rx 263. (Z)-4-Tridecenal-Rx 264. 13-Acetyloxytridecanal-Rx 265. Tridecanal-Rx 266. (E)-l l,13-Tetradecadienal-Rx 267. (E,E)-8,10-Tetradecadienal-Rx 268. (E,Z)-4,9-Tetradecadienal-Rx 269. (Z)-l l,13-Tetradecadienal-Rx 270. (Z)-5-Tetradecenal-Rx 271. (Z)-7-Tetradecenal-Rx 272. (Z)-9,13-Tetradecadien-11 -ynal-Rx 273. (Z,E)-9,12-Tetradecadienal-Rx 274. (Z,Z)-8,10-Tetradecadienal-Rx 275. (Z,Z)-9,11-Tetradecadienal-Rx 276. i 0,12-Tetradecadienal-Rx 277. 2-Ethyltetradecanal-Rx 278. 3-oxo-13-Tetradecenal-Rx 279. 3-oxo-Tetradecanal-Rx WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018280. 5,8-Tetradecadienal-Rx 281. 5-Tetradecenal-Rx 282. (E)-5,9-Dimethyl-2-(6-methylhept-5-en-2-yl)-deca-4,8-dienal-Rx 283. (E,Z)-9,I1-Pentadecadienal-Rx 284. (Z)-1O-Pentadecenal-Rx 285. (Z)-6,14-Pentadecadienal-Rx 286. (Z,Z)-9,11-Pentadecadienal-Rx 287. 2-Hexyl-2-decenaERx 288. Pentadecanal-Rx 289. (lR)-Pimaral-Rx 290. (E)- 10-Hexadecenal-Rx 291. (E)-i 1-Hexadecenal-Rx 292, {E,E)-10,14- Hexadecadienal- Rx 293. (E,E)-1 l,13-Hexadecadienal-Rx 294. (E,E)-9,11-Hexadecadienal-Rx 295. (Ε,Ε,Ε)-10,12,14-Hexadecatrienal-Rx 296. (E,E,E)-3,7,1 l,15-teti-amethyl-2,6,10,14-hexadecatetraenal-Rx 297. (Ε,Ε,Ζ)-10,12,14-Hexadecatrienal-Rx 298. (E,E,Z)-4,6,11 -Hexadecatriertal-Rx 299. (Ε,Ε,Ζ,Z)-4,6,1 l,13-Hexadecatetraenal-Rx 300. (E,Z)-10,12-Hexadecadienal· Rx 301. (E,Z)-1 l,13-Hexadecadienal-Rx 302. (E,Z)-4,6-Hexadecadienal-Rx 303. (E,Z)-6,11-Hexadecadienal-Rx 304. (E,Z)-8,11-Hexadecadienal-Rx 305. (E,Z)-9,11 - Hexadecadienal-Rx 306. (Z)-10-Hexadecenal-Rx 307. (Z)- 12-Hexadecenal-Rx 308. (Z)-13-Hexadecen-1 l-ynal-Rx 309. (Z)-3-oxo-9-Hexadecenal-Rx 310. (Z,E)-10,12-Hexadecadienal-Rx 311. (Z,E)-11,13-Hexadecadie nal-Rx 312. (Z,E)-7,11-Hexadecadienal-Rx 313. (Z,E)-9,11-Hexadecadienal-Rx 314. (Z,Z)-10,12-Hexadecadienal-Rx 315. (Z,Z)-1l,13-Hexadecadienal-Rx 316. (Z,Z)-9,11 - Hexadecadienal- 317. 11-Hexadecynal-Rx 318. 2-Methylhexadecanal-Rx 319. 7-Hexadecenal-Rx 320. 9-Hexadecenal-Rx 321. (Z)-9-Heptadecenal-Rx 322. 1-Heptadecenal-Rx 323. 2-1leptadecenal-R, WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018324. Heptadecanal-Rx 325. {E)-l l-Octadecenal-Rx 326. (E)-13-Octadecenal-Rx 327. (E)-14-Octadecenal-Rx 328. (E)-2-Octadecenal-Rx 329. (E,E)-11,14-Octadecadienal-Rx 330. (E,Z)-2,13-Octadecadienal-Rx 331. (E,Z)-3,13-Octadecadienal-Rx 332. (Z)-11 -Octadecenal-Rx 333. (Z)-13-()ctadecenal-IT 334. (Z)-9-Octadecenal-Rx 335. (Z,Z)-11,13-Octadecadienal-Rx 336. (Z,Z)-13,15-Octadecadienal-Rx 337. (Z,Z)-3,13-Octadecadienal-Rx 338. (Z,Z)-9, i 2-Octadecadienal-Rx 339. (Z,Z,Z)-9,12,15-Octadecatrienal-Rx 340. 1 -Octadecenal-Rx 341. 9-OctadecenaERx 342. Octadecanal-Rx 343. (Z)-10-Nonadecenal-Rx 344. (Z)-9-Nonadecenal-Rx 345. (Z)-l 1-Eicosenal-Rx 346. 12-Deacetoxy-12-oxo-scalaradial-Rx 347. 1-Eicosenal-Rx 348. Deacetylscalaradial-Rx 349. Eicosanal-Rx 350. Scalaradial-Rx 351. Docosanal-Rx 352. Tetracosanal-Rx 353. Pentacosanal-Rx 354. Hexacosanal-Rx 355. Heptacosanal-Rx 356. Octacosanal-Rx 357. Triacontanal-Rx 358. Dotriacontanal-Rx - 4. The composition according to one of Claims 1-3, wherein the deuterium-enriched aldehyde is a pheromone and the composition is useful for modulating the behavior of insects.WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018
- 5. The composition according to Claim 4, further comprising: an optional additional component suitable for the composition, the component being selected from: a pesticide, solvent, dispensing material or device, and an adhesive capable of trapping an insect.
- 6. The composition according to one of Claims 1-5, wherein the deuterium isotope in Rx is in an amount greater than 50 percent of the hydrogen atoms present in Rx.
- 7. The composition according to one of Claims 1-5, wherein the deuterium isotope in Rx is in an amount greater than 90 percent of the hydrogen atoms present in Rx.
- 8. A method of modulating the behavior of insects, comprising: introducing a modulating composition to an area to be protected from the insects, the modulating composition, comprising a deuterium-enriched aldehyde of Claim 1.
- 9. The method of claim 8, wherein the deuterium-enriched aldehyde pheromone is selected from an aldehyde of Claim 2,
- 10. The method of claim 8, wherein the deuterium-enriched aldehyde pheromone is selected from an aldehyde of Claim 3.
- 11. The method according to one of Claims 8-10, wherein modulation, comprises: attracting an insect to a trap.WO 2014/145325PCT/US2014/0300652018208670 25 Jul 2018
- 12. The method according to one of Claims 8-10. wherein modulation, comprises: disruptin insect mating.
- 13. The method according to one of Claims 8-12, wherein the deuterium isotope in Rx is in an amount greater than 50 percent of the hydrogen atoms present in Rx.
- 14. The method according to one of Claims 8-12, wherein the deuterium isotope in Rx is in an amount greater than 90 percent of the hydrogen atoms present in Rx,
- 15. The method according to one of Claims 8-14, wherein the method further comprises: applying the pheromone to a surface of a trap wherein the insect enters but cannot leave,
- 16. The method according to one of Claims 8-14, wherein introducing, comprises:distributing the pheromone into the area to be protected, wherein the pheromone disrupts insect mating and is distributed impregnated on a chip, in a polymer hollow fiber, or adsorbed in a lubber septum.WO 2014/145325PCT/US2014/0300651/2OO o<NIT) <NO oo o<N oo o<NAir Oxidation of Benzaldehyde to Benzoic Acid
100% 90% fl ‘5 80% '5 a Φ 70% tt i> 60% •ϋ >> Λ Φ 50% 2 2 40%; N fl Φ 30%· S3 20% 10%· ()% -φ......w12 15Time (hours)SBenzaldehyde-D Renzaldehyde-I IFigure 1WO 2014/145325PCT/US2014/0300652/22018208670 25 Jul 2018Air Oxidation of Hexanal to Hexanoic Acid0 3 6 9 12 15 18 21 24Time (hours)0 3 6 9 12 15 18 21 24Time (hours)Tl Iexanal-11 sgl lexanal-DFigure 2
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018208670A AU2018208670B2 (en) | 2013-03-15 | 2018-07-25 | Deuterium-enriched aldehydes |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361787272P | 2013-03-15 | 2013-03-15 | |
US61/787,272 | 2013-03-15 | ||
US201361817006P | 2013-04-29 | 2013-04-29 | |
US61/817,006 | 2013-04-29 | ||
PCT/US2014/030065 WO2014145325A1 (en) | 2013-03-15 | 2014-03-15 | Deuterium-enriched aldehydes |
AU2014233179A AU2014233179B2 (en) | 2013-03-15 | 2014-03-15 | Deuterium-enriched aldehydes |
AU2018208670A AU2018208670B2 (en) | 2013-03-15 | 2018-07-25 | Deuterium-enriched aldehydes |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014233179A Division AU2014233179B2 (en) | 2013-03-15 | 2014-03-15 | Deuterium-enriched aldehydes |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2018208670A1 true AU2018208670A1 (en) | 2018-08-09 |
AU2018208670B2 AU2018208670B2 (en) | 2020-02-20 |
Family
ID=51527913
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014233179A Ceased AU2014233179B2 (en) | 2013-03-15 | 2014-03-15 | Deuterium-enriched aldehydes |
AU2018208670A Ceased AU2018208670B2 (en) | 2013-03-15 | 2018-07-25 | Deuterium-enriched aldehydes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014233179A Ceased AU2014233179B2 (en) | 2013-03-15 | 2014-03-15 | Deuterium-enriched aldehydes |
Country Status (10)
Country | Link |
---|---|
US (2) | US9023336B2 (en) |
EP (1) | EP2975931A4 (en) |
JP (1) | JP6670232B2 (en) |
KR (1) | KR102228670B1 (en) |
CN (2) | CN110506746A (en) |
AU (2) | AU2014233179B2 (en) |
BR (1) | BR112015023392A2 (en) |
MX (1) | MX2015012802A (en) |
RU (1) | RU2015141222A (en) |
WO (1) | WO2014145325A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9934665B1 (en) * | 2016-09-16 | 2018-04-03 | Ningsheng Zhang | Box edge security device |
WO2021045879A1 (en) * | 2019-09-03 | 2021-03-11 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Synthesis of deuterated aldehydes |
WO2021167055A1 (en) * | 2020-02-21 | 2021-08-26 | 長谷川香料株式会社 | Flavoring agent containing hydroxy aldehyde compound |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5299214A (en) * | 1976-02-16 | 1977-08-19 | Rikagaku Kenkyusho | Copulation inhibitor of rice stem borer |
JPS57150603A (en) * | 1981-03-13 | 1982-09-17 | Nitto Electric Ind Co Ltd | Body for controlling release of aldehyde type pheromone |
US4632829A (en) * | 1985-10-08 | 1986-12-30 | The United States Of America As Represented By The Secretary Of Agriculture | Sex pheromone composition for southwestern corn borer |
JPH0657665B2 (en) * | 1986-07-24 | 1994-08-03 | ユニチカ株式会社 | 2,2-Bis (4-hydroxy-2,6-d-2) -phenyl) propane and its production method |
US5149820A (en) * | 1987-03-11 | 1992-09-22 | Norsk Hydro A.S. | Deuterated compounds |
US4874780A (en) * | 1987-03-11 | 1989-10-17 | Norsk Hydro A.S. | Anticancer compounds |
JP2796629B2 (en) * | 1988-12-16 | 1998-09-10 | 日東電工株式会社 | Pheromone-containing polymer membrane |
GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
JP2793736B2 (en) * | 1992-01-29 | 1998-09-03 | 農林水産省農業環境技術研究所長 | Lawn pest spousal disruptors |
US6001346A (en) * | 1993-02-25 | 1999-12-14 | The Regents Of The University Of California | Aqueous emulsion comprising biodegradable carrier for insect pheromones and methods for controlled release thereof |
ATE372966T1 (en) | 1994-03-25 | 2007-09-15 | Isotechnika Inc | IMPROVED EFFECTIVENESS OF DRUGS THROUGH DEUTERATION |
JPH09241105A (en) * | 1996-03-05 | 1997-09-16 | Norin Suisansyo Sanshi Konchu Nogyo Gijutsu Kenkyusho | Sex attractant for anomalaalbopilosa albopilosa hope |
US7020996B2 (en) * | 2001-04-06 | 2006-04-04 | Morton Beroza | Method and system for remotely detecting trapped insects |
TW200413274A (en) * | 2002-12-27 | 2004-08-01 | Wako Pure Chem Ind Ltd | Deuteration or tritiation method |
US20080280970A1 (en) | 2007-05-08 | 2008-11-13 | Czarnik Anthony W | Deuterium-enriched atorvastatin |
US7531685B2 (en) | 2007-06-01 | 2009-05-12 | Protia, Llc | Deuterium-enriched oxybutynin |
US7915309B2 (en) | 2007-06-20 | 2011-03-29 | Protia, Llc | Deuterium-enriched oseltamivir |
US20080319007A1 (en) * | 2007-06-21 | 2008-12-25 | Protia, Llc | Deuterium-enriched montelukast |
TWI344167B (en) | 2007-07-17 | 2011-06-21 | Chunghwa Picture Tubes Ltd | Electron-emitting device and fabricating method thereof |
US7846912B2 (en) | 2007-09-13 | 2010-12-07 | Protia, Llc | Deuterium-enriched nelarabine |
US8026249B2 (en) | 2007-09-14 | 2011-09-27 | Deutena Pharmaceuticals, Inc. | Deuterium-enriched topotecan |
US7776866B2 (en) | 2007-09-15 | 2010-08-17 | Protia, Llc | Deuterium-enriched risperidone |
US7842675B2 (en) | 2007-09-15 | 2010-11-30 | Protia, Llc | Deuterium-enriched capecitabine |
US7956080B2 (en) | 2007-09-25 | 2011-06-07 | Protra, LLC | Deuterium-enriched SDX-101 |
US8658236B2 (en) | 2009-08-21 | 2014-02-25 | Deuteria Beverages, Llc | Alcoholic compositions having a lowered risk of acetaldehydemia |
US20120034288A1 (en) * | 2010-08-04 | 2012-02-09 | Mckibben Gerald H | Compositions and methods for enhanced attraction of noctuid moths |
-
2014
- 2014-03-15 RU RU2015141222A patent/RU2015141222A/en not_active Application Discontinuation
- 2014-03-15 AU AU2014233179A patent/AU2014233179B2/en not_active Ceased
- 2014-03-15 US US14/214,912 patent/US9023336B2/en active Active
- 2014-03-15 KR KR1020157029163A patent/KR102228670B1/en active IP Right Grant
- 2014-03-15 EP EP14764255.7A patent/EP2975931A4/en not_active Withdrawn
- 2014-03-15 MX MX2015012802A patent/MX2015012802A/en active IP Right Grant
- 2014-03-15 BR BR112015023392A patent/BR112015023392A2/en active Search and Examination
- 2014-03-15 WO PCT/US2014/030065 patent/WO2014145325A1/en active Application Filing
- 2014-03-15 JP JP2016503324A patent/JP6670232B2/en not_active Expired - Fee Related
- 2014-03-15 CN CN201910701311.3A patent/CN110506746A/en active Pending
- 2014-03-15 CN CN201480019652.8A patent/CN105101792A/en active Pending
-
2015
- 2015-04-07 US US14/680,065 patent/US9179670B2/en not_active Expired - Fee Related
-
2018
- 2018-07-25 AU AU2018208670A patent/AU2018208670B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR20150133758A (en) | 2015-11-30 |
JP6670232B2 (en) | 2020-03-18 |
RU2015141222A (en) | 2017-04-20 |
JP2016516727A (en) | 2016-06-09 |
WO2014145325A1 (en) | 2014-09-18 |
CN105101792A (en) | 2015-11-25 |
MX2015012802A (en) | 2016-06-17 |
EP2975931A1 (en) | 2016-01-27 |
KR102228670B1 (en) | 2021-03-18 |
AU2018208670B2 (en) | 2020-02-20 |
CN110506746A (en) | 2019-11-29 |
US9023336B2 (en) | 2015-05-05 |
AU2014233179B2 (en) | 2018-04-26 |
US20140271537A1 (en) | 2014-09-18 |
US20150208651A1 (en) | 2015-07-30 |
AU2014233179A1 (en) | 2015-10-01 |
EP2975931A4 (en) | 2016-11-02 |
BR112015023392A2 (en) | 2017-07-18 |
US9179670B2 (en) | 2015-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10058095B2 (en) | Deuterium-enriched aldehydes | |
Ansebo et al. | Antennal and behavioural response of codling moth Cydia pomonella to plant volatiles | |
AU2018208670B2 (en) | Deuterium-enriched aldehydes | |
JP5341269B2 (en) | Pest control method | |
KR102282322B1 (en) | Cockroach attraction-aggregation substance, cockroach aggregation attractant and cockroach controlling agent | |
FR2558730A1 (en) | THERMO-SPRAYABLE PRODUCTS AND DEVICE FOR ITS VAPORIZATION | |
JP5840029B2 (en) | Insect control agent | |
EP3503733A1 (en) | Insect repellent compounds and compositions, and methods thereof | |
AU2016204062A1 (en) | Carbonyl containing compounds for controlling and repelling Cimicidae populations | |
JP2013040132A (en) | Spray type flying insect pest repellent | |
EP3504968B1 (en) | Composition having sex pheromone activity on san jose scale, and attractant, mating disruptant, attraction method and mating disruption method for san jose scale | |
Klimavicz et al. | Monoterpenoid isovalerate esters as long-lasting spatial mosquito repellents | |
Lee et al. | Identification of sex pheromone components of Korean Dioryctria abietella (Lepidoptera: Pyralidae) population and synergism of pheromone and pine cone volatile blends | |
JP2005350469A (en) | Repellent for insect pest, or the like | |
US9497963B2 (en) | Methods and compositions for control of gypsy moth, Lymantria dispar | |
US20100297059A1 (en) | Methods and compositions for control of gypsy moths, lymanria dispar | |
JPS6342620B2 (en) | ||
JPH05271170A (en) | Amide compound and vermin-repellent and vermin extermination agent produced by using the compound | |
US20230232831A1 (en) | Monoterpenoid and phenylpropanoid carbonate esters and methods of their making and use as repellents | |
US20100190865A1 (en) | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar | |
US4563348A (en) | Sec-butyl (Z)-7-tetradecenoate and its use as a sex attractant for the grapeleaf skeletonizer | |
JP2013176313A (en) | Insect attractant | |
Class et al. | Patent application title: METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar Inventors: Erika Plettner (Burnaby, CA) Yongmei Gong (Beijing, CN) Regine Gries (Coquitlam, CA) | |
JP2003252707A (en) | Attractant for anomala lucens baillion | |
KR20050082822A (en) | An insecticide containing coriander oil and its chemical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |